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มนสัว ี ขนัธสม : การผลิตเปปไทดท่ี์มีคุณสมบติัในการยบัย ั้งเอนไซมเ์ปล่ียนรูป 
แองจิโอเทนซินจากหนงัปลาสวายโมง (PRODUCTION OF ANGIOTENSIN 
CONVERTING ENZYME (ACE) INHIBITORY PEPTIDES DERIVED FROM  
THAI PANGA SKIN) อาจารยท่ี์ปรึกษา : รองศาสตราจารย ์ดร.จิรวฒัน์  ยงสวสัดิกุล,  
120 หนา้. 
 
 หนงัปลาสวายโมงจดัเป็นวสัดุเหลือทิ้งจากกระบวนการผลิตเน้ือปลาสวายโมงแล่แช่แข็งซ่ึง
ปกติถูกทิ้งหรือแปรรูปเป็นอาหารสัตวท่ี์มีมูลค่าต ่า การผลิตเปปไทด์ท่ีมีคุณสมบติัยบัย ั้งเอนไซม์
เปล่ียนรูปแองจิโอเทนซินเป็นแนวทางหน่ึงในการน าหนังปลาสวายโมงมาใช้ประโยชน์อย่างมี
ประสิทธิภาพ อีกทั้งยงัเป็นการเพิ่มมูลค่าให้กบัหนงัปลาสวายโมง การน าหนงัปลามาใชเ้ป็นสารตั้ง
ตน้ยงัไม่มีการศึกษามากนกั วตัถุประสงคข์องการศึกษาน้ีคือ เพื่อเปรียบเทียบคุณสมบติัในการยบัย ั้ง
กิจกรรมเอนไซมเ์ปล่ียนรูปแองจิโอเทนซินของโปรตีนไฮโดรไลเสทท่ีผลิตจากหนงัปลาสวายโมง 
ในรูปแบบต่าง ๆ 3 รูปแบบ ได้แก่  หนังปลาท่ีผ่านการก าจดัไขมนั หนังปลาท่ีผ่านการแช่ด้วย
สารละลายด่างและกรด และเจลาติน โดยถูกย่อยด้วยเอนไซม์โปรติเอสทั้งหมด 6 ชนิด ได้แก่     
แอลคาเลส เพปซิน ทริปซิน โปรตาเมกซ์ และโปรติเอสจากเช้ือ Virgibacillus halodenitrificans SK 
1-3-7 วดัระดบัการยอ่ยสลายและการยบัย ั้งกิจกรรมเอนไซมเ์ปล่ียนรูปแองจิโอเทนซินท่ี 12 ชัว่โมง 
ผลการศึกษาพบว่าชนิดของโปรติเอส และรูปแบบของสารตั้งตน้มีอิทธิพลต่อระดบัการย่อยสลาย
และการยบัย ั้งกิจกรรมเอนไซมเ์ปล่ียนรูปแองจิโอเทนซินของโปรตีนไฮโดรไลเสท (P<0.05) ค่าการ
ยบัย ั้งกิจกรรมเอนไซม์เปล่ียนรูปแองจิโอเทนซินจ าเพาะสูงท่ีสุด คือ ร้อยละ 4.9 ต่อไมโครกรัม
ไกลซีนสมมูล ในตวัอย่างหนงัปลาท่ีแช่ดว้ยสารละลายด่างและกรดท่ีย่อยดว้ยเพปซิน ค่ากิจกรรม
การยบัย ั้งเอนไซมเ์ปล่ียนรูปแองจิโอเทนซินเพิ่มข้ึนตามระยะเวลาในการยอ่ยสลาย และค่ากิจกรรม
การยบัย ั้งมีค่าสูงท่ีสุดเม่ือยอ่ยเป็นระยะเวลา 12 ชัว่โมง อยา่งไรก็ตามค่าดงักล่าวใกลเ้คียงกบัท่ียอ่ย
เป็นเวลา 2 ชัว่โมง (P>0.05) โปรตีนไฮโดรไลเสทท่ียอ่ยดว้ยเพปซินเป็นเวลา 2 ชัว่โมงจึงถูกน ามา
แยกดว้ยเทคนิคอลัตราฟิลเตรชนั โดยใชเ้ยื่อกรองขนาด 30 5 และ 1 กิโลดาลตนัตามล าดบั โปรตีน
ไฮโดรไลเสทท่ีมีขนาดเล็กกว่าเยื่อกรองขนาด 1 กิโลดาลตนัแสดงค่าการยบัย ั้งกิจกรรมเอนไซม์
เปล่ียนรูปแองจิโอเทนซินสูงท่ีสุด คือ ร้อยละ 49.8 ท่ีความเขม้ขน้เปปไทด์ 25 ไมโครกรัมสมมูล
ไกลซีนต่อมิลลิลิตร และเม่ือน าส่วนดงักล่าวมาแยกต่อดว้ยเทคนิคโครมาโทกราฟฟ่ีแบบแลกเปล่ียน
ประจุลบและแบบแยกตามขนาด ตามล าดบั เปปไทด์หลงัจากท าบริสุทธ์ิบางส่วนแสดงค่าการยบัย ั้ง
กิจกรรมเอนไซม์เปล่ียนรูปแองจิโอเทนซินคิดเป็นร้อยละ 53.8 ท่ีความเข้มข้นเปปไทด์  25 
ไมโครกรัมสมมูลไกลซีนต่อมิลลิลิตร และความเข้มข้นของเปปไทด์ท่ีสามารถยบัย ั้งกิจกรรม
เอนไซม์เปล่ียนรูปแองจิโอเทนซินร้อยละ 50 (IC50) มีค่าเท่ากบั 19 ไมโครกรัมสมมูลไกลซีนต่อ
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มิลลิลิตร ผลการวิเคราะห์ LC-MS/MS พบว่าตวัอย่างหลงัจากการแยกด้วยโครมาโทกราฟฟ่ีตาม
ขนาดประกอบดว้ยเปปไทด์ท่ีมีกรดอะมิโนชนิดท่ีไม่มีขั้ว (ลิวซีนและวาลีน) กรดอะมิโนชนิดท่ีมี  
วงแหวน (ทริปโตแฟน และไทโรซีน) หรืออาร์จินีน ท่ีต าแหน่งสุดทา้ยของสายเปปไทด์ เปปไทด์
เหล่าน้ีมีขนาดมวลโมเลกุลอยู่ระหว่าง 0.7-1.5 กิโลดาลตนั การยบัย ั้งกิจกรรมเอนไซม์เปล่ียนรูป 
แองจิโอเทนซินลดลงร้อยละ 30 หลังผ่านการย่อยในระบบทางเดินอาหารแบบจ าลอง ผลการ
ทดลองบ่งช้ีวา่โปรตีนไฮโดรไลเสทท่ีมีสมบติัการยบัย ั้งกิจกรรมเอนไซมเ์ปล่ียนรูปแองจิโอเทนซิน
สามารถผลิตไดจ้ากหนงัปลาสวายโมงท่ีผา่นการแช่ดว้ยสารละลายด่างและกรด และยอ่ยดว้ยเพปซิน 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
สาขาวชิาเทคโนโลยอีาหาร ลายมือช่ือนกัศึกษา ___________________________  
ปีการศึกษา 2557 ลายมือช่ืออาจารยท่ี์ปรึกษา _____________________  
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MANATSAWEE  KHUNTASOM : PRODUCTION OF ANGIOTENSIN 
CONVERTING ENZYME (ACE) INHIBITORY PEPTIDES DERIVED 
FROM THAI PANGA SKIN. THESIS ADVISOR : ASSOC. PROF. 
JIRAWAT  YONGSAWATDIGUL, Ph.D., 120 PP. 
 
THAI PANGA SKIN/ANGIOTENSIN CONVERTING ENZYME INHIBITORY 
PEPTIDE/PROTEIN HYDROLYSATE   
 
 Thai Panga (Pangasius hypopthalmus  P. bocourti) (Pangasius hypopthalmus 
 P. bocourti) skin is a by-product of the frozen fillet industry which is normally 
discarded or converted into low-value animal feed. The production of ACE inhibitory 
peptides may be an efficient utilization that can increase the value of Thai Panga skin. 
The use of whole skin as a substrate has not yet been fully investigated. The objective 
of this study was to compare the ACE inhibitory activity of protein hydrolysate 
produced from different forms of Thai Panga skin. Three forms of Thai Panga skin, 
namely defatted, alkaline-acid pretreated and gelatin, were used as a substrate for 
hydrolysis by 6 proteases including Alcalase, pepsin, trypsin, papain, Protamex, and 
protease from Virgibacillus halodenitrificans SK 1-3-7. The degree of hydrolysis 
(DH) and ACE inhibitory activity at 12 h were measured. It was shown that the type 
of protease applied and substrate influenced DH and ACE inhibition (P<0.05). The 
highest specific ACE inhibitory activity of 4.9%/µg Gly equivalent (eq.) was obtained 
from the pepsin-hydrolyzed alkaline-acid pretreated skin. ACE inhibitory activity 
increased with hydrolysis time and showed the highest ACE inhibition at 12 h. 
However, it was comparable to that obtained at 2-h hydrolysis. The hydrolysate of 
pepsin at 2 h was subjected to sequential ultrafiltration membrane fractionation using 
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30-kDa, 5-kDa and 1-kDa molecular weight cut-off, respectively. Permeate obtained 
from the 1-kDa membrane showed the highest ACE inhibition of 49.8% at 25 µg Gly 
eq./mL. This active fraction was further fractionated using anion exchange 
chromatography and size-exclusion chromatography, respectively. The partially 
purified peptides showed ACE inhibitory activity of 53.8% at 25 µg Gly eq./mL with 
an IC50 of 19 µg Gly eq./mL. LC-MS/MS analysis revealed that potent fraction from 
size-exclusion chromatography contained peptides with hydrophobic (Leu or Val), 
aromatic (Trp or Tyr) residues or Arg at the ultimate position of peptides. The 
peptides exhibited molecular mass between 0.7 and 1.5 kDa. The ACE inhibitory 
activity of the partially-purified peptides decreased approximately 30% after in vitro 
simulated pepsin-pancreatin digestion. The results suggested that hydrolysate 
possessing ACE inhibitory activity can be produced using alkaline-acid pretreated 
Thai Panga skin hydrolyzed by pepsin.  
School of Food Technology      Student’s Signature__________________ 
Academic Year 2014     Advisor’s Signature__________________ 
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CHAPTER I 
INTRODUCTION 
 
1.1 Introduction 
 Hypertension is a symptom that systolic and diastolic blood pressure increase 
over 140 and 90 mmHg, respectively. It is a worldwide epidemic problem and also a 
key risk factor of heart and heart-related diseases (World Health Organization, 2013). 
Recent index revealed that 30% world population died by cardiovascular diseases, 
45% of heart disease and 51% of stroke mortality, which is related with hypertension 
(World Health Organization, 2013). The proportion of hypertensive patients is 
predicted to reach about 1.56 billion in 2025 (Kearney et al., 2005) 
 Hypertension is associated with abnormal of two physiological systems, which 
are renin-angiotensin system (RAS) and kallikrein-kinin system (KKS) (Regoli and 
Jr., 2015; Sayer and Bhat, 2014). These are regulated by a dipeptidyl carboxy 
metallopeptidase or angiotensin I converting enzyme (ACE, EC 3.4.15.1) (Fuchs       
et al., 2008; Natesh, Schwager, Sturrock, and Acharya, 2003). In RAS, ACE induces 
hypertension by generating the active vasoconstrictor, angiotensin II. Angiotensin II 
leads to vasoconstriction, sodium and fluid retention, resulting in hypertension. In 
KKS, ACE rapidly degrades vasodilatory agents, bradykinin and kallidin. Therefore, 
the inhibition of ACE is the major target to reduce blood pressure (Mentz et al., 2013). 
Although synthetic drugs provide beneficial effect, their adverse side effects including 
cough, taste disturbance, skin rash, and others are evident (Sica, 2010). This leads a 
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hypertensive patient (which naturally no symptom) to be difficult to comply with the 
therapy (Silverman and Holladay, 2015). ACE inhibitory peptides with non-toxicity, 
thus, have become an alternative compound for preventing hypertension (Hernández-
Ledesma, Contreras, and Recio, 2011). 
 ACE inhibitory protein hydrolysate/peptides are commonly produced by 
enzymatic hydrolysis (Kim and Wijesekara, 2010; Wang, Mao, Cheng, Xiong, and 
Ren, 2010). By this method, protease, protein substrate, and hydrolysis condition 
highly influence the release of ACE inhibitory peptides (Kim and Wijesekara, 2010). 
Commercial enzymes used to produce protein hydrolysates with ACE inhibitory 
activity include Alcalase, pepsin, trypsin, papain, and Protamex (Gómez-Guillén, 
Giménez, López-Caballero, and Montero, 2011; Hernández-Ledesma, Contreras, and 
Recio, 2011). In addition, the use of new sources of enzyme has frequently been 
reported. Protease from Virgibacillus halodenitrificans SK 1-3-7 isolated from Thai 
fish sauce fermentation (Montriwong, Kaewphuak, Rodtong, Roytrakul, and 
Yongsawatdigul, 2012) might potentially be used to produce protein hydrolysate 
exerting ACE inhibitory activity since it has been reported to produce ACE inhibitory 
peptides from tilapia  (Toopcham, Roytrakul, and Yongsawatdigul, 2015). 
 Both plants and animals are sources to generate ACE inhibitory peptides. 
Among them, collagenous materials seem to be valuable sources of ACE inhibitory 
peptides production because strong ACE inhibitory activity evidently associated with 
Pro residue in the peptide, particularly at the C-terminal position (Korhonen and 
Pihlanto, 2006).  
 Thai Panga (Pangasius hypopthalmus  P. bocourti) is a hybrid freshwater fish 
extensively bred at Northeast Thailand. It has a white flesh and mild flavor and has 
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become an economically important fishery product of Thailand. In 2014, 
approximately 340,000 tonnes of frozen pangasius fillet entered markets in more than 
70 countries (Food and Agriculture Organization of the United Nation, 2014). Fish 
skins which are discarded from processing plant may be utilized in production of 
protein hydrolysates with ACE inhibitory activity. 
 Fish skin mainly contains covalently cross-links of triple helical tropocollagen  
(Shoulders and Raines, 2009). This strong structure is difficult for enzymatic cleavage 
(Zhang, Olsen, Grossi, and Otte, 2013). Some previous studies about production of 
ACE inhibitory peptides from collagenous materials were carried out by disrupting the 
triple helical structure through boiling into uncoiled structure known as gelatin before 
use (Byun and Kim, 2001; Himay, Ngo, Ryu, and Kim, 2012; Lee, Jeon, and Byun, 
2011).  In gelatin preparation, skins are commonly pretreated by soaking in diluted 
alkaline and acid solution before thermal extraction (Jongjareonrak et al., 2010; Karim 
and Bhat, 2009). This chemical pretreatment contributes to non-covalent bond 
disruption so as to partially uncoil the helical structure to ease gelatin solubilization 
(Karim and Bhat, 2009). Pretreatment of fish skin by alkaline-acid solution might be 
sufficient to increase the accessibility of enzyme for releasing ACE inhibitory 
peptides. 
 In general, crude protein hydrolysate usually contains variant oligopeptides 
and some impurities (Clemente, 2000). Ultrafiltration in combination with liquid 
chromatography can isolate and enrich ACE inhibitory peptides with desirable size, 
charge and hydrophocity (Li-Chan, 2015). Since ACE inhibitory activity is strongly 
influenced by the first three residues from C-terminus, amino acid sequencing would 
indicate the interaction between ACE inhibitory peptide and ACE active site  
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(Asoodeh et al., 2014; Byun and Kim, 2002; Li et al., 2014; Rohit, Sathisha, and 
Aparna, 2012; Vercruysse et al., 2010). 
 ACE inhibitory peptides must undergo digestion by pepsin and pancreatic 
enzymes  (Barrett, Ghishan, Merchant, Said, and Wood, 2006). This might affect the 
modification of peptides, leading to an increase or decrease in their biological activity 
prior to reach the target site in vivo (Alemán, Gómez-Guillén, and Montero, 2013; 
Barrett, Ghishan, Merchant, Said, and Wood, 2006). A simulated in vitro peptic-
pancreatic digestion is a promising way to predict the fate of ACE inhibitory peptide 
in the digestive system (Hur, Lim, Decker, and McClements, 2011). It provides a 
convenient and reproducible process with lower cost to evaluate the efficacy of the 
peptides of interest (Hartmann and Meisel, 2007). 
 The purpose of this study was to evaluate ACE inhibitory activity of protein 
hydrolysates produced from Thai Panga skin, which was prepared by different 
treatments, namely defatted skin, alkaline-acid pretreated skin and gelatin. The skins 
were hydrolyzed by commercial proteases including Alcalase, pepsin, trypsin, papain, 
Protamex and protease from Virgibacillus halodenitrificans SK 1-3-7. Fractionation 
was carried out using consecutive ultrafiltration, anion exchanger and size-exclusion 
chromatography. Amino acid sequencing of partially-purified peptide was performed 
by LC-MS/MS. The partially-purified peptides were subsequently subjected into a 
simulated in vitro peptic-pancreatic digestion to predict its stability in gastrointestinal 
tract system. 
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1.2 Research objectives 
The objectives of this study were: 
1. To produce and compare ACE inhibitory potency of protein hydrolysates 
produced from skins of Thai Panga in different forms, namely defatted skin, alkaline-
acid pretreated skin and gelatin, and hydrolyzed by commercial and Virgibacillus 
halodenitrificans SK 1-3-7 proteases  
2. To select the suitable form of substrate, protease and hydrolysis time to 
produce protein hydrolysates with ACE inhibitory activity.  
3. To partially-purify the potent ACE inhibitory peptides and analyze their 
amino sequences.   
4. To determine the stability of ACE inhibitory peptides against simulated 
pepsin-pancreatin digestion. 
  
1.3 Research hypotheses  
 Thai Panga skin has potential as a raw material for the production of ACE 
inhibitory protein hydrolysates. Form of substrate and proteases provide the different 
ACE inhibitory activity among protein hydrolysates. Partial purification can improve 
crude protein hydrolysates. Gastrointestinal proteases could affect ACE inhibitory 
activity of the peptides.  
 
1.4 Scope of the study 
The defatted skin, alkaline-acid pretreated skin and gelatin of Thai Panga were 
hydrolyzed by commercial proteases, including Alcalase, pepsin, trypsin, papain 
Protamex; and protease from Virgibacillus halodenitrificans SK 1-3-7. The degree of 
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hydrolysis and ACE inhibitory activity of protein hydrolysates were determined. The 
suitable substrate and protease were selected to produce protein hydrolysates for ACE 
inhibition. The optimal hydrolysis time for ACE inhibitory peptide production was 
evaluated. Crude protein hydrolysate was further partially purified by consecutive 
ultrafiltration, anion exchange chromatography and size exclusion chromatography. 
The peptide sequences were analyzed by LC-MS/MS. The stability against simulated 
pepsin-pancreatin digestion of partially-purified peptides was elucidated. 
 
1.5 Expected results 
 This research would lead to an efficient utilization of Thai Panga skin. 
Production and ACE inhibitory peptides characteristics would be critical information 
for bioactive peptide research from Thai Panga skin. The peptides would be a prospect 
as a nutraceutical product with the potential to prevent hypertension.  
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CHAPTER II 
LITERATURE REVIEW   
 
2.1 Thai Panga  
Thai Panga (Pangasius hypopthalmus × P. bocourti) or common Thai name 
“Pla Sawai Mong” is a freshwater fish in family Pangasiidae. It is a hybrid between 
female Pangasius hypopthalmus (trade name “Tra” or Thai name “Pla Sawai”) and 
male Pangasius bocourti (trade name “Basa” or “Pla Mong” in Thai) (Hatachote, 
Sriphairoj, and Na-Nakorn, 2009). It has a rounded head and blunt snout similar to    
P. bocourti. The stout body without scale has a dark grey dorsum. Dorsal, pectoral and 
pelvic fins are also dark grey. In addition, it has a silvery side and white belly. 
Specifically, it has a greenish tint stripe from a dorsal fin to a caudal fin, the unique 
characteristic which distinguishes from their breeding fish (Figure 2.1). 
  
  
 
Figure 2.1 Thai Panga (Pangasius hypopthalmus × Pangasius bocourti) 
Source: Modified from http://www.komchadluek.net 
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 The inland fisheries of Thai Panga located at Northeast Thailand along the 
Maekhong River. Reproduction of Thai Panga fish is achieved by inducing broodfish 
to spawn using hormone injections and incubating eggs in conical shape jars, 
fiberglass tanks or water recirculation system at 27-29
o
C. The eggs later hatch to 
larvae within 24 hours and are transferred to a nursery concrete or earthen pond. 
Juvenile are commonly fed by artemias, rotifers, small crustaceans or boiled egg yolk 
while pelleted feed is suitable for a mature fish. Thai Panga can be harvested after 6-8 
months with a weight of about 1 kg (Kaewla, Arpakulanu, Chumnongsittathum, and 
Nilsri, 2011; Manee and Tangprakhon, 2008). 
Hybrid fish is a prolific spawner and produces relatively large numbers of 
larvae equal to its female broodfish, while it has a firm texture and mild flavor similar 
to P. bocourti. This advantage is currently promoted as a new economically important 
fishery product of Thailand competing with Vietnamese Pangasius (Thiparos, 2014; 
Tulyapongrak, Ratana-Arporn, and Runglerdkriangkrai, 2008). Recently 
approximately 340,000 tonnes of frozen pangasius fillet entered markets in more than 
70 countries in 2014 where European Union, Latin America and Asia were the major 
markets (Food and Agriculture Organization of the United Nation, 2014).  
Studies on Thai Panga fish are mostly concerned with farming practices 
(Kaewla, Arpakulanu, Chumnongsittathum, and Nilsri, 2011; Manee and 
Tangprakhon, 2008). The post-harvest studies of Thai Panga are involved with the 
frozen fillet products. Tulyapongrak, Ratana-Arporn, and Runglerdkriangkrai (2008) 
studied the physical, chemical and microbiological changes of Thai Panga fish during 
chilled storage and indicated that electrical properties as measured by Torymeter and 
K-value can be used as freshness index for Thai Panga fish. Thipbharos (2014) 
implied that geosmin content in frozen Thai Panga fish fillets could be reduced using 
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ozone, banana leaf ash or sodium chloride solutions based on  SPME-GC/MS analysis 
and sensory evaluation. However, utilization of Thai Panga waste, particularly skin, 
has not been widely studied. Disposal of Thai Panga skins is presently accomplished 
by converting to an animal feed with low returns.   
 
2.2  Fish skin protein  
 The dermis layer of fish skin comprises high concentration of structural 
proteins (elastin and collagen) that could be converted to high value products in food, 
pharmaceutical, cosmeceutical and biomedical products  (Cho, Jin, Rha, Kim, and 
Hwang, 2014; Morimur et al., 2002). The collagen fibrous forming to a connective 
tissue of fish skin is assembled from many collagen fibrils, which each collagen fibril 
is formed by cross linking of individual tropocollagen (Figure 2.2)  (Shoulders and 
Raines, 2009). Tropocollagen, a primary strucrure of collagen comprises three 
polypeptide left-hand α-chain helices. Each α-helix chains are twisted together into a 
right hand triple helix. Each helix chain contains a repeating of Gly-X-Y as a primary 
sequence, where X and Y are high possibility to be Pro and Hyp (Shoulders and 
Raines, 2009). The structure of tropocollagen is stabilized by hydrogen bonding 
between Gly and Pro of neighboring chains (Shoulders and Raines, 2009). 
Additionally, inter-chain hydrogen bonds can be formed between water molecule and 
hydroxyl group of amino acid at Y position. At the N- and C-terminal of helical 
structure has short non-helical domains namely, telopeptides. Telopeptides has a role 
in fibril formation and stabilization thereby the oxidation of Lys side chain in their 
molecules (Shoulders and Raines, 2009). Most of 29 collagen types, animal skin 
principally contain type I collagen, whose structure normally composed of two α1 (I) 
and one α2 (I) chains (Gorgieva and Kokol, 2011). Fish skin collagen contains a 
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variety of amino acids and it has less content of proline and hydroxylproline but 
higher in serine and threonine than that of land mammals (Karim and Bhat, 2009).  
 
 
 
Figure 2.2 Tropocollagen is held by hydrogen bonds between Gly and Pro of 
neighboring chain (d). Tropocollagens covalently cross-link to form 
collagen fibril, and many collagen fibrils assemble into collagen fiber of 
the skin (c, a, b).  
Source: Modified from Shoulders and Raines (2009). 
 
 The usage of collagen is mostly related to their functional property including 
gelling, emulsifying, film and foaming agent in food, cosmetic as well as biomedical 
industry  (Gómez-Guillén, Giménez, López-Caballero, and Montero, 2011; Karim and 
Bhat, 2009). Many researchers attempted to optimize the extraction condition for 
improving the functional properties of fish skin collagen and gelatin in the past 
a b 
c d 
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decade. However, number studies showed that collagen and gelatin from fish skin has 
poor functional property when compared with that of commercial products derived 
from bovine and porcine organ. This might be due to lower imino acid content in the 
fish skin when compared with that of land mammal (Ahmad, Benjakul, and 
Nalinanon, 2010; Cheow, Norizah, Kyaw, and Howell, 2007; Karim and Bhat, 2009; 
Kasankal, Xue, Weilong, Hong, and He, 2007; Lassoued et al., 2014; Nagai and 
Suzuki, 2002; Nagai, Yamashita, Taniguchi, Kanamori, and Suzuki, 2001; Nikoo et 
al., 2014; Olsen, Toppe, and Karunasagar, 2014; Zeng et al., 2009). 
Collagen and gelatin have also been reported as sources of biologically active 
peptides (Banerjee and Shanthi, 2012; Gómez-Guillén, Giménez, López-Caballero, 
and Montero, 2011). Bioactivities of collagen- and gelatin-derived peptides, such as 
antimicrobial activity, mineral binding capacity, lipid lowering effect, 
immunomodulatory activity, antihypertensive/ACE inhibitory activity and 
antioxidative activity have been reported (Gómez-Guillén, Giménez, López-Caballero, 
and Montero, 2011). Among them, the studies about collagen and gelatin derived 
peptides have greatly dealt with antihypertensive or ACE inhibitory properties. Since 
Pro residues in repeating Gly-Pro-Hyp of collagen have associated with high 
antihypertensive properties (Cheung, Wang, Ondetti, Sabo, and Cushman, 1980; 
Korhonen and Pihlanto, 2006).  
 
2.3 Angiotensin I converting enzyme (ACE) 
2.3.1 Structural and biochemical properties of angiotensin I-converting 
enzyme (ACE) 
Angiotensin I-converting enzyme (ACE; EC 3.4.15.1) or other designations 
i.e. kininase II, peptidyl-dipeptidase A, dipeptidyl carboxy peptidase I, carboxy 
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cathepsin, dipeptide hydrolase and peptidase P, is a zinc metallopeptidase belonging 
to gluzincin family of metalloproteases  (Barrett, Rawlings, and Woessner, 2004). In 
human, there are two distinct isoforms which are encoded by the same gene including 
somatic ACE (sACE) and germinal or testis ACE (gACE or tACE, respectively) 
(Barrett, Rawlings, and Woessner, 2004). Both forms are membrane bound protein 
and can be released as a soluble enzyme into extracellular fluids via the proteolytic 
cleavage by secretase or sheddase (Guang, Phillips, Jiang, and Milani, 2012). 
Germinal ACE is a smaller isozyme found exclusively in testis and responsible in 
germinal cell differentiation (Bernstein et al., 2013). The enzyme contains a single 
catalytic active domain identical to C-domain of sACE, except for a unique 67-residue 
sequence constituting its NH2 (Ehlers, Fox, Strydom, and Riordan, 1989). It comprises 
732 amino acids and a molecular weight of around 90-110 kDa (Barrett, Rawlings, 
and Woessner, 2004). C-domain of tACE has been used as a representative of sACE 
to study the interaction between ACE inhibitor and ACE active site (Guy, Lambert, 
Warner, Hooper, and Turner, 2005).  
The larger isozyme, sACE (molecular weight 150-180 kDa) contains 1306 
amino acids and can be detected in a variety of tissues, particularly abundant on the 
endothelial surface of lung and kidney (Riordan, 2003; Turner and Hooper, 2002). Its 
integral membrane protein composes of an intracellular domain, hydrophobic 
transmembrane region and extracellular domain (Bernstein et al., 2013). The 
extracellular domain is divided into two highly homologous domains including C-
domain and N-domain (Barrett, Rawlings, and Woessner, 2004). Structurally, both 
domains have predominance of α-helices and the overall shape is an ellipse. The 
active site groove is positioned at the central structure and has a lid-like structure 
covering the active site channel that restrict the access of large polypeptide to the 
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active site, which both domains contain a sequence His-Glu-Met-Gly-His, a zinc 
binding ligand for catalytic activity (Regulska, Stanisz, Regulski, and Murias, 2014; 
Sturrock, Natesh, Rooyen, and Acharya, 2004; Williams, Corvol, and Soubr, 1994).  
By analogy with carboxypeptidase A and thermolysin, Cushman and Ondetti 
(1984) proposed a predictive model of ACE active site which thereafter became a 
template for ACE inhibitor designs. In this model, ACE active site comprises three 
binding subsites (S1, S1’, and S2’) for interacting with the substrate ligand. The zinc 
ion between S1 and S1’ is an enzyme cofactor that assists to reduce the activation 
energy for hydrolysis of peptide bond via increasing the electrophillicity to the 
carbonyl oxygen of the oligopeptide substrate and nucleophillicity to the water 
molecule. The position between S1 and S1’subsite is a hydrogen bond donor (H-X). A 
positive charge site is located next to S2’ for binding the terminal carboxyl group of 
substrates (Figure 2.3).  
 
 
 
Figure 2.3 The predictive model of ACE active site binding with a venom peptide. 
Source: Cushman and Ondetti (1984). 
 
 C-domain requires monovalent anions, notably chloride for the activation 
whereas N-domain can be completely activated without chloride (Sturrock, Natesh, 
Rooyen, and Acharya, 2004). ACE shows the optimal activity at 37
o
C, pH 8.3 and 
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requires 300 mM NaCl for its activation (Barrett, Rawlings, and Woessner, 2013). The 
enzyme could be inhibited by EDTA and other metal chelating agents and can be 
reactivated by manganese, zinc and cobalt (Cushman, Cheung, Sabo, and Ondetti, 
1977). It has the diversity of substrate specificity in vitro due to the individual amino 
acid sequence at the active site of each domain (Rioli et al., 2003). The role in blood 
pressure regulation, both domains responsibly degrade a vasodilator, bradykinin in 
kallikrein-kinin system, while only C-domain of sACE mainly produces a 
vasoconstrictor, angiotensin II in renin angiotensin system  (Sayer and Bhat, 2014).  
 2.3.2 Renin-angiotensin and kallikrein-kinin system  
Renin-angiotensin-aldosterone system (RAAS) or renin-angiotensin system 
(RAS) is the hormone system, responsible for the regulation of blood pressure, sodium 
and fluid homeostasis and tissue repair via inflammatory and proliferative 
mechanisms (Mentz et al., 2013). The RAS enzymatically cascade (the pathway which 
is involved in angiotensin production) begins when the liver-produced 
angiotensinogen (α2-globulin) is released into the circulation and renin (aspatyl 
protease, EC 3.4.23.15) is released from juxtaglomerular cells of the kidney (Guang, 
Phillips, Jiang, and Milani, 2012). Renin then generates the inactive decapeptide 
angiotensin I (Ang I, Ang 1-10, Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu) from 
anhiotensinogen as shown in Fig. 2.3. Ang I is cleaved at the C-terminal dipeptide, 
His-Leu, by angiotensin converting enzyme (ACE) at the endothelial surface of blood 
vessels, producing the critical active vasoconstrictor, angiotensin II (Ang II, Ang 1-8, 
Asp-Arg-Val-Tyr-Ile-His-Pro-Phe ) (Mentz et al., 2013). Ang II could exert biological 
effects by interacting with the specific receptor including type-1 angiotensin (AT1) 
receptor and type-2 angiotensin (AT2) receptor (Kloet, Krause, and Woods, 2010). 
Although AT2 receptor is able to regulate the renal function and blood pressure  
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(Tikellis, Cooper, and Thomas, 2006), most of physiological actions are mainly 
induced by Ang II- AT1 receptor complex including: vasoconstriction, stimulation of 
the synthesis and release of aldosterone; sodium reabsorption from the renal tubule; 
cardiac growth; proliferation of vascular smooth muscle; increase in peripheral 
noradrenergic activity and central activity of sympathetic nervous system; stimulation 
of the release of vasopressin; and inhibition of renal renin (Contreras et al., 2002). The 
excessive activity of RAS is recognized as a key role for the development of 
pathological changes in the arterial wall which is a cardiovascular risk factor in 
subjects with essential hypertension (Contreras et al., 2002). 
 Those deleterious effects of RAS can be counteracted by kallikrein-kinin 
system (KKS) (Regoli and Jr., 2015). It is an enzymatic system implicated in blood 
pressure regulation and inflammation through bradykinin and related kinins, which are 
produced by two proteolysis pathways including plasma and tissue kallikrein (Saxena, 
Thompson, Udekem, and Konstantinov, 2011). Plasma kallikrein produces the 
vasoactive peptide, bradykinin (Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg), by 
hydrolyzing high molecular weight kinigonen, while tissue kallikrein hydrolyzes low 
molecular weight kininogen liberating Lys-bradykinin or kallidin (Albert-
Weißenbergera, Sirén, and Kleinschnitz, 2013). Both bradykinin and kallidin can be 
further converted into des-Arg9 bradykinin and des-Arg10 kallidin, respectively, by 
carboxypeptidase (kininase I) (Albert-Weißenbergera, Sirén, and Kleinschnitz, 2013). 
Lys-bradykinin can be transformed into bradykinin by proteolysis of aminopeptidase 
(Golias, Charalabopoulos, Stagikas, Charalabopoulos, and Batistatou, 2007). The two 
kinin derivatives functionally exert the inflammatory response by mediation of G-
protein-coupled receptor, B1 receptor, while bradykinin and kallidin primarily bind to 
B2 receptor (Saxena, Thompson, Udekem, and Konstantinov, 2011). Mediation of B2 
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receptor is implicated in hypotension by vasodilation, which is involved reduction of 
systemic vascular resistance, diuresis and sodium excretion by a kidney (Regoli and 
Jr., 2015). However, these efficient vasodilatory agents have a short life; they are 
largely inactivated in the lung vasculature and limited amounts could reach the arterial 
blood (Regoli and Jr., 2015). Bradykinin and kallidin can be rapidly destroyed into 
inactive vasodilatory peptides by enzymatic hydrolysis of kininase II or ACE. 
Therefore, inhibition of ACE is a dual mechanism which could not only reduce the 
impact of RAS but also potentiate the activity of KKS (Regoli and Jr., 2015). 
 
 
 
Figure 2.4 Role of ACE in blood pressure regulation. 
Source: Li, Leu, Shi, and Shresthaa (2004).  
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  2.3.3 Pharmaceutical ACE inhibitors  
ACE inhibitors are one class of antihypertensive drugs which are regularly 
used in the treatment of hypertension and related cardiovascular diseases (Mentz et al., 
2013). The venom extract of Bothrop jararaca (nonapeptide teprotide, SQ 20,881, 
BPP9a, Glu-Trp-Pro-Arg-Pro-Gln-Ile-Pro-Pro) was found as the first agent possessing 
ACE inhibitory effect and bradykinin potentiating activity (Ferreira, Bartelt, and 
Greene, 1970; Ng and Vane, 1970). Owing to the unavailability by oral 
administration, it was unsuccessfully used as an antihypertensive drug (Bhuyan and 
Mugesh, 2011). Later the first orally active ACE inhibitor, captopril (captoten, SQ 
14,225) was approved by U.S.FDA.  It has been the breakthrough for exploitation of 
other ACE inhibitors (Cushman et al., 1997). The inhibitors which are commonly 
prescribed for hypertensive patients can be categorized into three subgroups including: 
1) sulfhydryl (-SH) containing inhibitors e.g. captopril, zofenopril; 2) dicarboxylate   
(-COOH) containing inhibitors e.g. lisinopril, enalapril, benazepril, quinapril, ramipril, 
trandolapril; and 3) phosphate (-PO2) containing inhibitor i.e. fosinopril (Figure 2.5) 
(Atlas, 2007). These inhibitors are divided based on the zinc-chelating group 
presenting in their structure (Bhuyan and Mugesh, 2011). The sulfhydryl-containing 
drugs bind to zinc ion through the SH group, leading to the formation of zinc (II)-
thiolate (Figure 2.5). The carboxyl-containing drugs interact through carboxylate 
group and fosinopril interacts through the phosphate group. Other functional groups 
are required for ACE inhibitors including terminal carboxyl group for ionic interaction 
with a positively charge residue and a central carbonyl oxygen is required to act as 
hydrogen bond acceptor (Regulska, Stanisz, Regulski, and Murias, 2014). In addition, 
N-terminal phenyl residue is preferably obligated by S1subsite and proline is 
necessary for the interaction with S2’ subsite. ACE inhibitory drugs block the action of 
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ACE as a competitive inhibitor. Captopril and lisinopril are an active drug while other 
inhibitors are ester-containing prodrugs which require in vivo hepatic and intestinal 
wall esterolysis to generate the active form to attack ACE (Regoli and Jr., 2015).  
 
 
 
Figure 2.5 Structures of ACE inhibitor drugs coordinating with the active site of 
ACE via their carboxyl groups, whereas captopril and fosinopryl 
coordinate via sulfhydryl and phosphoryl groups, respectively.  
Source: Williums et al. (1996). 
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 ACE inhibitors produce positive outcomes and have achieved widespread 
usage in the treatment of hypertension, cardiovascular diseases, and renal disease 
(Sica, 2010). Nonetheless, both physiological and nonphysiological adverse effects 
have been the basis for ACE inhibitors therapy (Sica, 2010). Dry cough is a frequent 
undesirable effect initiated by ACE inhibitors, accounting for 3.9% of patients (Regoli 
and Jr., 2015). Another serious side effect is angioedema. The inhibitors increase risk 
of foetopathy for the usage during the third trimester of pregnancy and they cause 
malformation for the exposure to ACE inhibitors during the first trimester of 
pregnancy (Guang, Phillips, Jiang, and Milani, 2012). The physiological consequences 
include hypotension, deterioration of renal function, and hyperkylemia (Atlas, 2007). 
Furthermore, toxic effects associated mainly with captopril including taste disturbance 
(metallic and salty taste), skin rash, neutropenia, hepatic toxicity, and proteinuria 
(membranous nephropathy) (Atlas, 2007). 
 
2.4  ACE inhibitory peptides 
Unacceptable side effects of synthetic drugs provoke the search of natural 
ACE inhibitors, since they provide a safer, milder and lower cost alternative for 
preventing high blood pressure (Erdmann, Cheung, and Schröder, 2008; Gu, 
Majumder, and Wu, 2011; Hernández-Ledesma, Contreras, and Recio, 2011). 
Bioactive peptides exhibiting diverse physiological functions have been isolated from 
various sources. ACE inhibitory peptides showed the inhibition mechanisms 
distinctive from that of synthetic ACE inhibitors. The synthetic drugs deactivate ACE 
by competitively chelating Zn
2+
 buried at the active site of ACE via any of sulfhydryl, 
phosphoryl, and carboxylate group (Atlas, 2007). Unlike the synthetic drug, ACE 
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inhibitory peptides use their C-terminal amino acid residues to inhibit ACE by some 
of hydrogen bonding, van der Waals interaction, electrostatic interaction or 
hydrophobic interaction with the amino acid residues located at either the catalytic site 
or other binding site of ACE as a competitive, non-competitive, uncompetitive and 
mixed ACE inhibitor depending on molecular characteristics of the peptide (Asoodeh 
et al., 2014; Banerjee and Shanthi, 2012; Jimsheena and Gowda, 2011; Li et al., 2014; 
Vercruysse, Camp, Morel, Rouge´, Herregods, and Smagghe, 2010). Many studies 
concurred that ACE inhibitory activity of peptides is considerably dependent on their 
C-terminal amino acid residues (Gómez-Guillén, Giménez, López-Caballero, and 
Montero, 2011; Harnedy and FitzGerald, 2012; Hernández-Ledesma, Contreras, and 
Recio, 2011; Lafarga and Hayes, 2014).    
 Typically, peptides are not active within the original protein structure even 
though they can be released from their parent proteins by gastrointestinal digestion or 
during food processing (Hernández-Ledesma, Contreras, and Recio, 2011). Those 
peptides may also be produced by other procedures such as enzymatic hydrolysis, acid 
or alkaline hydrolysis, and microbial fermentation, resulting in a crude protein 
hydrolysate (He, Liu, and Ma, 2013; Kim and Wijesekara, 2010). Among them, 
enzymatic hydrolysis is considered as an effective method for ACE inhibitory protein 
hydrolysates and peptide production (Harnedy and FitzGerald, 2012; Li-Chan, 2015; 
Wang, Mao, Cheng, Xiong, and Ren, 2010).  
 2.4.1 Production of ACE inhibitory peptides by enzymatic hydrolysis  
Enzymatic hydrolysis is a common process used to produce ACE inhibitory 
hydrolysates and peptides (Kim and Wijesekara, 2010; Wang, Mao, Cheng, Ren, and 
Xiong, 2010). It is carried out under mild condition with an ability to control product 
quality without residual organic solvent or toxic chemicals in the products when 
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compared with acid and alkaline hydrolysis (Agyei and Danquah, 2011; Clemente, 
2000; He, Franco, and Zhang, 2013). By this method, protease and protein substrate 
are crucial factors governing structural features of peptides (molecular size, amino 
acid composition, peptide chain length, peptide sequence and amount of peptides), 
which, in turn, influence ACE inhibitory potency of peptides (Kim and Wijesekara, 
2010). Furthermore, hydrolysis time and substrate pretreatment also contributed to the 
improvement of ACE inhibitory activity of protein hydrolysates (Skierka and 
Sadowska, 2007). 
2.4.1.1  Proteases for ACE inhibitory peptide production  
  Proteolytic enzymes using for ACE inhibitory peptides production are 
generally obtained from plants, microbes and animals (Hernández-Ledesma, 
Contreras, and Recio, 2011). Since the ability of enzymes to hydrolyze protein 
substrates is highly variable, the selection of suitable enzyme to produce peptides with 
desired bioactive properties is essential (Clemente, 2000). The commercial food-grade 
proteases which have been widely used for preparing ACE inhibitory peptide include 
Alcalase, pepsin, trypsin, papain, and Protamex (Gómez-Guillén, Giménez, 
López-Caballero, and Montero, 2011; Hernández-Ledesma, Contreras, and Recio, 
2011). 
  Alcalase (EC 3.4.21.62), a serine endoprotease secreted by Bacillus 
licheniformis, has a broad specificity and high specificity toward aromatic amino 
acids, Glu, Met, Leu, Ala, Ser and residues in peptide chains (Wong, 1995). It is the 
most efficient in the hydrolysis of food proteins (He, Liu, and Ma, 2013). The high 
degree of hydrolysis can be achieved in a relatively short time (Gómez-Guillén, 
Giménez, López-Caballero, and Montero, 2011). The enzyme has a potential to 
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produce potent ACE inhibitory peptides with low molecular weight in various plant 
and animal proteins (Ahhmed and Muguruma, 2010; Erdmann, Cheung, and Schröder, 
2008; He, Liu, and Ma, 2013). Furthermore, some studies reported that Alcalase 
hydrolsates exhibited the highest ACE inhibitory activity compared to other enzymes 
(Ahn, Jeon, Kim, and Je, 2012; Alemána et al., 2011; Lee, Qian, and Kim, 2010; Ngo, 
Ryu, and Kim, 2014; Zhang, Olsen, Grossi, and Otte, 2013) 
Pepsin (EC 3.4.23.1) is an aspatic protease family generally found in 
the gastric juices of vertebrates (Barrette, Rawlings, and Woessner, 2004). It 
preferably cleaves peptide bonds at aromatic amino acid residues (Phe, Tyr, Trp), Leu 
and Asp at carboxyl side of a peptide bond (Whitaker, 1994). Previous studies 
indicated that pepsin showed highly ACE inhibitory activity in vitro, those peptides 
contain hydrophobic amino acid residues at C-terminal which can interact with ACE 
active site (Dub et al., 2013; Muguruma et al., 2009).  
  Trypsin (EC 3.4.21.4) is a serine endopeptidase produced in pancreas 
and preferably cleaves peptide bond at the carboxyl side of peptide bond containing 
Arg and Lys (Barrette, Rawlings, and Woessner, 2004). Tryptic peptides exerting high 
ACE inhibitory activity have been found in plants, animals and animal products 
(Asoodeh et al., 2014; Hou et al., 2012; Lee, Jeon, and Byun, 2014; Power, 
Fernández, Norris, Riera, and FitzGerald, 2014; Tanzadehpanah, Asoodeh, Saberi, and 
Chamani, 2013). 
  Papain (EC 3.4.22.2) is a cysteine protease found in the latex of 
tropical papaya fruit (Carica papaya) (Barrette, Rawlings, and Woessner, 2004). The 
enzyme has a fairly broad substrate specificity (Whitaker, 1994). Using papain 
individually or in combination with Alcalase and trypsin could increase ACE 
inhibitory activity of various animal and plant peptides (Asoodeh, Yazdi, and 
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Chamani, 2012; Gu, Li, Liu, Yi, and Cai, 2011; Ngoa, Ryu, Voa, Himaya, and Kim, 
2011; Rui, Boye, Simpson, and Prasher, 2013).  
  Protamex is a food grade commercial endoprotease produced from 
Bacillus subtilis with a wide specificity for peptide bonds (Wang et al., 2010). It is an 
inexpensive protease and could be used to produce ACE inhibitory peptides from 
marine wastes (Thi et al., 2011; Tsai, Chen, and Pan, 2008; Tsai, Lin, Chen, and Pan, 
2006). It has been reported that fish waste (mackerel and cod bone and skin) 
hydrolysate prepared from Protamex showed the highest ACE inhibitory activity 
compared to Alcalase and Flavourzyme (He et al., 2007). 
  Protease from Virgibacillus halodenitrificans SK 1-3-7, a subtilisin-
like serine protease, was isolated from Thai fish sauce fermentation. The enzyme is 
stable between pH 4 -10 and below 60
o
C and showed high catalytic activity toward 
fibrin (Montriwong, Kaewphuak, Rodtong, Roytrakul, and Yongsawatdigul, 2012). 
Proteases secreted from Virgibacillus sp. have a broad specificity and high catalytic 
acivity toward fish protein (Sinsuwan, Rodtong, and Yongsawatdigul, 2010). The 
enzyme has been applied to produce protein hydrolysates with bioactive properties 
from both plant and animal origins (Arunachalam, Amirtham, and Appadorai, 2013; 
Lapsongphon and Yongsawatdigul, 2013; Wiriyaphan, Xiao, Decker, and 
Yongsawatdigul, 2015).  
  2.4.1.2 Protein sources for ACE inhibitory peptides production 
  Protein substrates are another vital factor affecting ACE inhibitory 
activity. The unique peptide sequence with diverse amino acid compositions were 
directly affected by protein substrates. Protein hydrolysates or peptides exhibiting 
ACE inhibitory activity or antihypertensive property found in previous studies could 
be derived from various food proteins including plants, animals and animal products. 
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  Plant-derived ACE inhibitory peptides found in previous studies were 
mostly isolated from protein hydrolysates of cereals and cereal by-products. The 
cereals were used as substrates in enzymatic hydrolysis including rapeseed (He et al., 
2013; Kinenen, Johannson, Gerd, Pihlava, and Pihlanto, 2012; Marczak et al., 2003; 
Yu et al., 2013), canola (Wu, Aluko, and Muir, 2008, 2009), peanut (Quist, Phillips, 
and Saalia, 2009), sunflower (Megı´as et al., 2009), lima bean  (Torruco-Uco, Chel-
Guerrero, Martı´nez-Ayala, Da´vila-Ortı´z, and Betancur-Ancona, 2009), jamapa bean 
(Torruco-Uco et al., 2009), amaranth (Tovar-Pérez, Guerrero-Legarreta, Farrés-
González, and Soriano-Santos, 2009), wheat (Qua, Ma, and Zhao, 2013), chickpea 
(Barbana and Boye, 2010), yellow pea (Barbana and Boye, 2010), lentil (Barbana and 
Boye, 2011; Boye, Roufik, Pesta, and Barbana, 2010), cowpea  (Segura-Campos, 
Chel-Guerrero, and Betancur-Ancona, 2011), arachin (Jimsheena and Gowda, 2010, 
2011), chia (Segura-Campos, Salazar-Vega, Chel-Guerrero, and Betancur-Ancona, 
2013), soybean (Gu and Wu, 2013), rice (Chen, Liu, Ye, Cai, Jic, and Wu, 2013), 
hemp seed (Girgiha et al., 2014), red bean (Durak, Baraniak, Jakubczyk, and wieca, 
2013; Rui, Boye, Simpson, and Prasheret, 2013), Parkia speciosa seed (Siow and 
Gan, 2013), lupin (Boschin, Scigliuolo, Resta, and Arnoldi, 2014), pistachio (Li et al., 
2014), and brewers’ spent grain (Connolly, O’Keeffe, Piggott, Nongonierma, and 
FitzGerald, 2015). Among those sources, peptides derived from rice (VNP, VWP at 5 
mg/kg body weight ), rapeseed (LY, RALP at 0.15 g/kg body weight ), and hemp seed 
(WVYY, PSLPA at 30 mg/kg body weight) showed antihypertensive activity in 
spontaneously hypertensive rats (SHR) after oral administration (Chen et al., 2013; 
Girgiha et al., 2014; He et al., 2013).  
  Protein hydrolysates exerting ACE inhibitory activity derived from 
muscle protein including myofibrillar, sarcoplasmic, and connective tissue of aquatic 
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as well as terrestrial animals were extensively studied. Myofibrillar proteins used to 
generate ACE inhibitory peptides could be obtained from porcine skeletal (Arihara, 
Nakashima, Mukai, Ishikawa, and Itoh, 2001; Castellano, Aristoy, Sentandreu, 
Vignolo, and Toldráb, 2013; Muguruma et al., 2009), travelly (Salampessy, Reddy, 
Kailasapathy, and Phillips, 2015), lizard (Wu, Feng, Lan, Xu, and Liao, 2015), goby 
(Nasria et al., 2013) , grass carp (Chen, Wang, Zhong, Wu, and Xia, 2012), haruan 
(Ghassem, Arihara, Babji, Said, and Ibrahim, 2011), seaweed pipefish (Wijesekara, 
Qian, Ryu, Ngo, and Kim, 2011), tilapia (Raghavan and Kristinsson, 2009), atlantic 
salmon (Nakajima, Yoshie-Starka, and Ogushi, 2009), coho salmon (Nakajima, 
Yoshie-Starka, and Ogushi, 2009), Alaska Pollack (Nakajima, Yoshie-Starka, and 
Ogushi, 2009), southern blue whiting (Nakajima, Yoshie-Starka, and Ogushi, 2009), 
shark meat (Wu et al., 2008), bull frog muscle (Qian, Jung, Lee, Byun, and Kim, 
2007), cod (Jensen, Eysturskarð, Madetoja, and Eilertsen, 2014), and bonito (Fujita, 
Yamagami, and Ohshima, 2001). Peptides isolated from porcine myosin B (KRVIQY, 
VKAGF), chicken muscle (IKW, LAP, LKP), bull frog (GAAQLPCSADWW) as well 
as cod protein hydrolysates could show hypotensive effect in SHR (Muguruma et al, 
2009; Qian, Jung, Lee, Byun, and Kim, 2007). Furthermore, peptide soup containing 
LKPNM derived from dried bonito was approved as Foods for Specified Health Use 
in Japan and has already been commercialized in a variety trade names (Vasotensin 
120T, PeptACE, or Peptides 90) (Fujita, Yamagami, and Ohshima, 2001; Hartmann 
and Meisel, 2007). ACE inhibitory peptides can also be derived from sarcoplasmic 
protein hydrolysates. Bovine brisket (Bernardini et al., 2012), porcine globin (Yu et 
al., 2006), beef rump (Jang and Lee, 2005), and sipunculid worm (Dub et al., 2013) 
were example of water soluble protein resources which have been found in the 
literatures. Peptides, AWLHPGAPKVF derived from sipunculid worm could reduce 
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systolic blood pressure of SHR when orally administered at a dose of 10 mg/kg rat 
body weight. Connective tissues, particularly skins, were recommended as a potential 
substrate for producing ACE inhibitory peptides since they are a rich source of 
collagen containing a unique sequence (Gly-Pro-Hyp) through its triple helix structure 
(Gómez-Guillén, Giménez, López-Caballero, and Montero, 2011). The oligopeptides 
containing Pro especially at C-terminal end were reported to inhibit ACE activity 
effectively (Korhonen and Pihlanto, 2006). Mostly, the substrate used to release ACE 
inhibitory peptides from connective tissues were in the form of collagen or gelatin. 
Collagenous materials which have been employed to produce collagen hydrolysates 
for ACE inhibition include squid (Alemán, Gómez-Guillén, and Montero, 2013), sea 
bream scales (Fahmi et al., 2004), jelly fish (Liu, X., Zhang, M., Zhang, C., and Liu, 
C., 2012) and bovine Achilles tendon (Banerjee and Shanthi, 2012; Yuhao Zhang, 
Olsen, Grossi, and Otte, 2013), Alaska pollack skin (Byun and Kim, 2001, 2002), sea 
cucumber (Zhao et al., 2007), Pacific cod skin (Himay, Ngo, Ryu, and Kim, 2012; 
Ngoa, Ryu, Voa, Himaya, and Kim, 2011), squid (Alemán, Giménez, Pérez-Santin, 
Gómez-Guillén, and Montero, 2011; Lin, Lv, and Li, 2012), Atlantic salmon skin (Gu, 
Li, Liu, Yi, and Cai, 2011), duck skin (Lee et al., 2012), blacktip shark 
(Kittiphattanabawon, Benjakul, Visessanguan, and Shahidi, 2013), and thornback ray 
(Lassoued et al., 2015), skate skin (Lee, Jeon, and Byun, 2011; Ngo, Ryu, and Kim, 
2014), chicken skin (Onuh, Girgih, Aluko, and Aliani, 2013), chum salmon skin (Lee, 
Jeon, and Byun, 2014), Alaska pollock frame (Hou et al., 2012), yellowfin sole frame 
(Jung et al., 2006), tuna frame (Lee, Qian, and Kim, 2010), and salmon pectoral fin 
(Ahn, Jeon, Kim, and Je, 2012). Collagen resources which were potentially produced 
antihypertensive peptides included jelly fish collagen (QPGPT, GDIGT), sea 
cucumber gelatin (MEGAQE QGD), freshwater hard clam (VKP, VKK), oyster 
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(VVYPWTQRF), tuna frame (GDLGKTTTVSNWSPPKYKDTP), and yellow fin 
sole frame (MIFPGAGGPQL).  Some invertebrate animals, whole body of them were 
hydrolyzed into protein hydrolysates for elucidating their ACE inhibitory activity. 
These include oyster (Wang et al., 2008), cuttlefish (Balti et al., 2015; Balti, Nedjar-
Arroume, Bougatef, Guillochon, and Nasri, 2010), hard clam shellfish (Tsai, Chen, 
and Pan, 2008), golden fresh water clam (Tsai, Lin, Chen, and Pan, 2006), cotton 
leafworm (Vercruysse, Smagghe, Matsui, and Camp, 2008), and silkworm pupa (Jia, 
Wu, Yan, and Gui, 2015; Wu, Ji, Yan, Du, and Gui, 2014). 
  Egg and milk were also employed to produce ACE inhibitory peptides. 
Milk proteins are a primary source for ACE inhibitory peptides production (Korhonen 
and Pihlanto, 2006; Millsa, Ross, Hilla, Fitzgerald, and Stanton, 2011). Milk-
derivedACE inhibitory peptides from bovine, buffalo, goat, sheep, yak as well as 
donkey have been reported (Bidasolo, Ramos, and Gomez-Ruiz, 2012; Brandelli, 
Daroit, and Corrêa, 2015; Espejo-Carpio, Gobba, Guadix, Guadix, and Otte, 2013; 
Mao, Ni, Sun, Hao, and Fan, 2007; Rohit, Sathisha, and Aparna, 2012). ACE 
inhibitory peptides derived from bovine milk have been identified in both milk protein 
hydrolysates and fermented dairy products (Korhonen and Pihlanto, 2006). Casein (α-
casein, β-casein, κ-casein), whey (β-lactoglobulin and α-lactalbumin) and lactoferrin 
have been reported as good sources of ACE inhibitory peptides produced by 
enzymatic hydrolysis (Brandelli, Daroit, and Corrêa, 2015; Butylina, Luque, and 
Nystrom, 2006; Contreras, Carrón, Montero, Ramos, and Recio, 2009; Ferreira, et al., 
2007; FitzGerald and Meisel, 2000; Jiang, Tian, Brodkor, and Huo, 2010; Millsa, 
Ross, Hill, Fitzgerald, and Stanton, 2011; Ortiz-Chao et al., 2009; Otte, Shalaby, 
Zakora, Prippa, and El-Shabrawy, 2007; Pan, Cao, Guo, and Zhao, 2012; Power, 
Fernández, Norris, Riera, and FitzGerald, 2014; Ruiz-Giménez et al., 2012; Stressler, 
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Eisele, and Fischer, 2013; Yamada et al., 2013). Some examples of ACE inhibitory 
peptides, such as RYLGY, AYFYPEL derived from bovine casein hydrolysates and 
LIWKL, RPYL, LNNSRAP isolated from bovine lactoferrin hydrolysates could exert 
antihypertensive effect in SHR after oral administration (Contreras et al., 2009; Jiang, 
Tian, Brodkor, and Huo, 2010; Ruiz-Giménez et al., 2012). Hen egg yolk and egg 
white have frequently been reported as substrates for producing ACE inhibitory 
peptides. These also include isolated egg white proteins such as ovotransferrin, 
ovalbumin and lysozyme (Asoodeh, Yazdi, and Chamani, 2012; Eckert et al., 2014; 
Fujita, Eiichiyokoyama, and Yoshikawa, 2000; Liu et al., 2010; Majumder and Wu, 
2011; Pokora et al., 2014; Rao et al., 2012). In addition, the use of turtle and ostrich 
egg white protein for ACE inhibitory peptides production has been investigated 
(Rawendra et al., 2013; Tanzadehpanah, Asoodeh, Saberi, and Chamani, 2013). ACE 
inhibitory peptides derived from ovalbumin (LW), egg white hydrolysates (IQW, 
LKP) could reduce blood pressure of SHR after orally administered at doses of 10 
mg/kg rat body weight (Fujita et al., 2000; Majumder and Wu, 2011).  
  ACE inhibitory protein hydrolysates derived from other alternative 
resources have been studied, such as shrimp head and scales (He et al., 2008 ), insect 
(Vercruysse, Smagghe, Matsui, and Camp, 2008), skip jack roe (Intarasirisawat, 
Benjakul, Wu, and Visessanguan, 2013), head and viscera of sardinella (Bougatef et 
al., 2008), rotifer (Lee, Hong, Jeon, Kim, and Byun, 2009), button mushroom (Lau, 
Abdullah, Shui, and Aminudin, 2014), marine algae (Koa et al., 2012; Lin et al., 2012; 
Qu et al., 2010; Sheih, Fang, and Wu, 2009), and pumpkin oil cake (Vaštag, Popovic´, 
Popovic´, Krimer, and Pericˇin, 2011). 
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2.4.1.3 Relationship between hydrolysis time and ACE inhibitory 
activity  
  Degree of hydrolysis (DH) is defined as the percentage of the total 
number of peptide bonds cleaved during hydrolysis. DH is a common indicator to 
monitor the extent of protein degradation (Adler-Nissen, 1979). The optimal DH of 
protein hydrolysate yields functional as well as biological property (Ferreiraa, et al., 
2007; Nasria et al., 2013; Spellman, McEvoy, O’Cuinn, and FitzGerald, 2003). DH of 
protein hydrolysates is directly related to ACE inhibitory activity (Balti et al., 2015; 
Jiang, Tian, Brodkor, and Huo, 2010; Nasria et al., 2013; Qu et al., 2010) and can be 
controlled through hydrolysis time (Otte, Shalaby, Zakora, Prippa, and El-Shabrawy, 
2007). It has been demonstrated that ACE inhibitory activity relied on DH only the 
first period of protein hydrolysis (Mao, Ni, Sun, Hao, and Fan, 2007; Megı´as et al., 
2009; Tovar-Pérez, Guerrero-Legarreta, Farrés-González, and Soriano-Santos, 2009). 
During the first proteolysis progression, numbers of smaller peptides were released 
from their parent protein (Nagai, Yamashita, Taniguchi, Kanamori, and Suzuki, 2001; 
Torruco-Uco, Chel-Guerrero, Martı´nez-Ayala, Da´vila-Ortı´z, and Betancur-Ancona, 
2009). Some of them have a suitable chain length and C- and N-terminal amino acid 
residues could exert inhibitory activity towards ACE (Nasria et al., 2013; Salampessy, 
Reddy, Kailasapathy, and Phillips, 2015).  
2.4.1.4 Influence of substrate pretreatment on ACE inhibitory 
activity  
Thermal and non-thermal treatments are known to lead to the 
degradation and aggregation of protein (Hammond and Jez, 2011; Verhoeckx et al., 
2015). Several investigations have applied these treatments to pre-treat protein 
substrate prior to enzymatic hydrolysis in order to enhance ACE inhibitory activity. 
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The process which have been employed in the pretreatment process including 
ultrasonic (Jia et al., 2010; Jia, Wu, Yan, and Gui, 2015; Ma, Huang, Peng, Wang, and 
Yang, 2015; Zhou, Ma, Yu, Liu, Yagou, and Pan, 2013), heating (Zhang, Olsen, 
Grossi, and Otte, 2013; Rui et al., 2012) and high pressure (Banerjee and Shanthi, 
2012). The studies showed that ultrasonic pretreatment increased ACE inhibitory 
activity of protein hydrolysate (Jia et al., 2010; Jia et al., 2015; Ma et al., 2015; Zhou 
et al., 2013). The optimal power and time could induce molecular unfolding and 
increase surface hydrophobicity, which facilitated the release of ACE inhibitory 
peptides from the protein (Jia et al., 2010). On the contrary, exceeding ultrasonic time 
and power could induce re-association or aggreagation to form more stable structure, 
hindering the release of ACE inhibitory peptides (Jia, Wu, Yan, and Gui, 2015). Zhou, 
Ma, Yu, Liu, Yagoub, and Pan, (2012) revealed that pre-heat treatment of bean protein 
isolates by boiling for 15 min yielded higher ACE inhibitory activities for the navy 
and small red beans hydrolysates compared to the unheated sample. This was likely 
due to unfolding of the compact structure of the parent proteins by heat. However, no 
improvement was found for pre-thermal treatment of black bean hydrolysates during 
Alcalase and Flavourzyme hydrolysis. SDS-PAGE pattern showed that this might be 
related to the large protein aggregation after heating of protein isolates, limiting the 
liberation of ACE inhibitory peptides. Zhang, Olsen, Grossi, and Otte, (2013) 
demonstrated that boiling collagen for 5 min before hydrolysis could rise ACE 
inhibitory activity of collagen hydrolysate compared with untreated collagen. They 
suggested that boiling induced the cleavage of hydrogen and covalent bonds, resulting 
in helix to coil transition, making the inner site more accessible to the enzyme. In this 
study, ACE inhibitory activity of collagen hydrolysate was not increased when pre-
treated with high pressure (600 MPa, 15 min). This might be that under high pressure, 
 
 
 
 
 
 
 
 
31 
 
some intramolecular hydrogen bonds were disrupted and some new hydrogen bond 
with water molecule formed, leading to more stabilization of the triple helix structure. 
Consequently, the Pro-rich parts of collagen, which give rise ACE inhibitory activity, 
were not exposed after high pressure pre-treatment. 
Apart from protease, protein substrate, suitable hydrolysis time as well 
as substrate pretreatment; enzyme and substrate ratio (Boschin, Scigliuolo, Resta, and 
Arnoldi, 2014; Lassoued et al., 2015; Onuh, Girgih, Aluko, and Aliani, 2013; 
Rawendraa et al., 2013; Roufik, Gauthier, and Turgeon, 2006; Tomatsu, Shimakage, 
Shinbo, Yamada, and Takahashi, 2013), pH (Roufik, Gauthier, and Turgeon, 2006), 
and temperature (Cheison, Schmitt, Lee, Letzel, and Kulozik, 2010; Rawendra et al., 
2013) were also key factors affecting  protein hydrolysis. 
 2.4.2 Fractionation of ACE inhibitory protein hydrolysates 
Crude protein hydrolysate might not exhibit good biological activity since they 
contain variant oligopeptides and some impurities (Clemente, 2000). Membrane and 
liquid chromatography are therefore used as a means for fractionation and isolation of 
bioactive peptides from the crude hydrolysates (Li-Chan, 2015). Ultrafiltration has 
been more preferably applied in the large scale food production due to its fast and 
comparatively inexpensive as compared to a chromatographic technique (Agyei and 
Danquah, 2011; Raghavan and Kristinsson, 2009). In the laboratory, membrane 
filtration is commonly used in the initial step before chromatographic purification 
(Hatti-Kaul and Mattiasson, 2003). The target proteins or peptides are fractionated 
based mainly on the molecular mass (Janson, 2011). In ACE inhibitory peptide 
fractionation, the different MWCO membrane between 1-30 kDa was generally used 
and the strongest ACE inhibitory peptides were normally obtained from the permeate 
of the lowest MWCO-membrane, which showed ACE inhibitory activity higher than 
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that of crude hydrolysate (Chen et al., 2013; Chen, Wang, Zhong, Wu, and Xia, 2012; 
Dub et al., 2013; Eckert et al., 2014; Ghassem, Arihara, Babji, Said, and Ibrahim, 
2011; Jiang, Tian, Brodkor, and Huo, 2010; Jung et al., 2006; Koa et al., 2012; Lee, 
Qian, and Kim, 2010; Lin, Lv, and Li, 2012; Mao, Ni, Sun, Hao, and Fan, 2007; 
Salampessy, Reddy, Kailasapathy, and Phillips, 2015; Segura-Campos, Chel-
Guerrero, and Betancur-Ancona, 2011; Wu, Jia, Yan, Du, and Gui, 2014; Zhao et al., 
2007). This corresponds to the fact that small peptides contribute to the ACE 
inhibitory activity of protein hydrolysates and short peptide sequences are good 
candidates for in vivo physiological antihypertensive agent (Hernández-Ledesma, 
Contreras, and Recio, 2011). 
 To isolate the potent active peptides, fractionated protein hydrolysate should 
be further subjected to the column chromatography [size exclusion (SEC), ion 
exchange chromatography (IC), or reverse-phase chromatography (RPC)] (Lafarga 
and Hayes, 2014). However, they are restrictive for the large scale application due to 
the high production cost (Agyei and Danquah, 2011).  Nonetheless, they seemed to be 
effective in the laboratory scale, particularly for further identification and 
characterization (Korhonen and Pihlanto, 2006). The characteristics such as molecular 
mass, amino acid composition, peptide length, and peptide sequence are certainly 
useful in elucidating the ACE inhibition behavior of peptide as well as the interaction 
between the inhibitory peptide and ACE active site (Asoodeh et al., 2014; Byun and 
Kim, 2002; Li et al., 2014; Rohit, Sathisha, and Aparna, 2012; Vercruysse Vercruysse, 
Camp, Morel, Rouge´, Herregods, and Smagghe, 2010). Moreover, they are also 
beneficial to predict the digestibility (Boye, Roufik, Pesta, and Barbana, 2010; 
Contreras, Sanchez, Sevilla, Recio, and Amigo, 2013; Majumder and Wu, 2011; Ruiz-
Giménez et al., 2012) and stability of an ACE inhibitory peptide undergoing extreme 
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food processing condition (Miguel, Alonso, Salaices, Aleixandre, and Lo´pez-
Fandin˜o, 2007; Wang et al., 2008). This knowledge will pave the way for further 
production of antihypertensive peptides in aspect of protein and enzyme selection, 
hydrolysis optimization, and purifying condition.  
 2.4.3 Structural characteristics of potent ACE inhibitory peptides 
 The certain ACE inhibition model of food-derived peptides is still not 
established since the potent food-derived ACE inhibitory peptides have a diversity of 
amino acid composition, sequence, length and inhibition mechanism (competitive, 
non-competitive, uncompetitive or mixed-inhibitor) (Jao, Huang, and Hsu, 2012). The 
potency of ACE inhibitory peptides is dependent on peptide chain length and strongly 
influenced by hydrophobicity of amino acid residues at the ultimate position of 
peptides (Hong et al., 2008). Potent ACE inhibitory peptides normally contain 3-13 
amino acids and have molecular weight of 500-1500 Da (Li, Leemail, Shi, and 
Shrestha, 2004). ACE inhibitory activity inversely correlated to the peptide length 
since the large peptides are hindered by the small cavity of ACE active site (Natesh, 
Schwager, Sturrock, and Acharya, 2003). The potent peptides usually contain Pro, 
Lys, Arg, and hydrophobic amino acids at the ultimate position of peptides (Byun and 
Kim, 2002; Cheung, Wang, Ondetti, Sabo, and Cushman, 1980; Li, Leemail, Shi, and 
Shrestha, 2004; Wu, Aluko, and Nakai, 2006b). The structure-activity relationship 
revealed that potent ACE inhibitory dipeptide should have a hydrophobic amino acid 
(Phe, Trp, Ala, Val, Leu, Ile, Met) at the C-terminus and a non-polar amino acid or 
positively charged amino acid (Lys, Arg) at the N-terminus (Wu, Aluko, and Nakai, 
2006b). In case of tripeptides, the most favorable residues for the C-terminus are 
aromatic amino acids (Tyr, Phe, Trp), while branched chain hydrophobic amino acids 
(Val, Ile, Leu) are preferred for the N-terminus and positively charged amino acids 
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(Lys, Arg) are preferred for the middle position  (Wu, Aluko, and Nakai, 2006b).      
C-terminal tetrapeptide residues of long-chain peptides (4-10 amino acid residues) 
were more important to their ACE-inhibitory activity than C-terminal tripeptide 
residues. The most preferred amino acid residues starting from C-terminus are Tyr and 
Cys for the first position; His, Trp and Met for the second position; with Ile, Leu, Val 
and Met for the third position; and Trp for the fourth position (Wu, Aluko, and Nakai, 
2006a). Ondetti and Cushman (1982) proposed that hydrophobic amino acids and Pro 
at the C-terminal tripeptide contribute to strong binding with sub-active sites (S’, S1’ 
and S2’) of ACE. Meisel (1993) speculated that the positive charge on the guanidine 
or ε-amino group of the C-terminal Arg and Lys side chain interacted with other 
anionic binding site of ACE apart from its catalytic site (FitzGerald and Meisel, 
2000). Table 2.1 shows primary sequence of potent ACE inhibitory peptides derived 
from various food protein sources.  
2.4.4 In vitro ACE inhibitory activity assay  
In vitro assay has been applied to screen potent food-derived antihypertensive 
peptides (Hernández-Ledesma, Contreras, and Recio, 2011). Several methods with 
different substrates and analytical techniques have been found (Hernández-Ledesma, 
Contreras, and Recio, 2011). However, the method developed by Cushman and 
Cheung (1971) is the most common generally employed by numerous researchers. 
The assay is based on the hydrolysis of synthetic tripeptide, Hip-His-Leu by ACE 
(with and without the inhibition by bioactive peptides) under the specific condition 
(300 mM NaCl in 0.1 M borate buffer, pH 8.3 at 37
o
C) to generate His-Leu and 
hippuric acid residue (Barrett, Rawlings, and Woessner, 2013; Cushman and Ondetti, 
1984). The activity of ACE could obtain by the measurement of hippuric acid after 
extraction by ethyl acetate. The chromatographic technique based on HPLC was 
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recognized for quantifying the releasing hippuric acid at 228 nm. It provides more 
accurate and reproducible results (Boschin, Scigliuolo, Resta, and Arnoldi, 2014; 
Shalaby, Zakora, and Otte, 2006). The inhibitory potency is usually expressed as the 
IC50 value, which is a concentration needed to inhibit 50% of the enzyme activity 
(Hernández-Ledesma, Contreras, and Recio, 2011). 
 
 
 
Figure 2.6 Hydrolysis of Hip-His-Leu tripeptides by ACE. 
From: Bhuyan and Mugesh (2011). 
 
2.4.5 In vitro gastrointestinal digestion of ACE inhibitory peptides 
Dietary proteins and peptides after ingested must undergo the digestion firstly 
by pepsin in the stomach and are further hydrolyzed by several pancreatic digestive 
enzymes when enter the small intestine (Barrett, Rawlings, and Woessner, 2006). The 
action of pepsin together with pancreatic enzymes [trypsin which acts on peptide 
bonds with cationic amino acids (Arg, Lys, His); α-chymotrypsin which prefers to 
hydrolyze peptide bond at aromatic amino acids (Phe, Tyr, Trp); elastase which 
preferably cleaves at Ala, Ser, and Gly; carboxypeptidase A which habitually liberates 
amino acids at the C-terminal excepting Lys, Arg, and Pro; and carboxypeptidase B 
which favors the peptides towards C-terminal Arg and Lys] might affect the 
modification of bioactive peptides that finally increase or decrease their biological 
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activity prior to reach the target function in the body (Alemán, Gómez-Guillén, and 
Montero, 2013; Barrett, Rawlings, and Woessner, 2006). Although in vivo studies can 
provide a reliable result, it is costly and time-consuming process, in vitro screening 
assays are more preferably employed (Hartmann and Meisel, 2007). Peptic-pancreatic 
incubation seems to be a promising in vitro model to predict whether ACE inhibitory 
activity of peptides in the digestive system (Hur, Lim, Decker, and McClements, 
2011). Several studies have adopted this approach (Escudero, Mora, and Toldrá, 2014; 
Hur, Lim, Decker, and McClements, 2011; Hwang, 2010; Lau, Abdullah, Shuib, and 
Aminudin, 2014; Majumder and Wu, 2011; Miguel, Alonso, Salaices, Aleixandre, and 
Lo´pez-Fandin˜o, 2007; Tsai, Chen, and Pan, 2008; Wu, Jia, Yan, Du, and Gui, 2014). 
Peptide chain length and amino acid composition of peptide are important factors 
determining ACE inhibitory activity. Long chain peptides are highly susceptible to 
proteolytic enzymes in the gastrointestinal tract, while short-chain peptides (2-4 amino 
acids) have more advantageous that they are less susceptible to hydrolysis by 
gastrointestinal tract enzymes (Quiros, Contreras, Ramos, Amigo, and Recio, 2009). 
Peptides containing Pro in their sequence tend to be resistant to gastric proteases 
hydrolysis, thus ACE inhibitory activity remains.  Fujita, Yokoyama, and Yoshikawa 
(2000) have classified ACE inhibitory peptides according to their modified 
characteristics after in vitro gastrointestinal incubation into three groups including true 
inhibitor, substrate type inhibitor, and pro-drug type inhibitor. True inhibitory peptides 
could preserve their ACE inhibitory activity after incubation by gastrointestinal 
proteases. The true inhibitors found in previous reports were mostly short chain 
peptides which could escape the gastrointestinal enzymes digestion such as peptide 
KHV which was derived from silkworm (Bombyx mori) (Wu, Jia, Yan, Du, and Gui, 
2014) and IQW, IRW, LKP from ovotransferrin hydrolysates (Majumder and Wu, 
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2011). In addition, long chain peptide containing Pro, such as VQLYP, LHLPLP, 
VQCYGPNRPQF which were derived from cuttlefish, β-casein and algae protein 
waste, respectively remained inhibitory activity after gastrointestinal digestion (Balti, 
Nedjar-Arroume, Bougatef, Guillochon, and Nasri, 2010; Quiros, Contreras, Ramos, 
Amigo, and Recio, 2009; Sheih, Fang, and Wu, 2009).  For substrate-type inhibitors, 
their ACE inhibitory activity decrease after the gastrointestinal incubation. The 
peptides in this group were mostly long chain which after the cleavage of 
gastrointestinal enzymes, the degraded peptides lost their overall ACE inhibitory 
activity. The substrate type peptides previously reported such as very long peptides 
derived from bovine tendon collagen, AKGANGAPGIAGAPGFPGARGPSGPQ-
GPSGPP and PAGNPGDGQPGAKGANGAP. Their ACE inhibitory activity 
decreased from 72.04% and 59.7% to 60.1% and 51.4%, respectively after 
gastrointestinal digestion (Banerjee and Shanthi, 2012). In addition, DKVGINY   
(IC50 = 84.2 µg/mL), KGYGGVSL (IC50 =253.6 µg/mL), DKVGINYW (IC50 = 25.2 
µg/mL) derived from whey protein concentrate were lost their ACE inhibitory activity 
with an increase in IC50 to  130.8, 336.3 and 254.5 µg/mL, respectively after partially 
hydrolyzed by gastric proteases (Ferreira et al., 2007). For pro-drug type inhibitors, 
when the peptides are hydrolyzed, they release true inhibitory fragment, resulting in 
an increase in ACE inhibitory activity. Pro-drug peptide inhibitor such as peptide 
MEGAQEAQGD from sea cucumber (Acaudina molpadioidea) showed ACE 
inhibitory activity after gastrointestinal incubation (IC50 = 5.3 µM), which was less 
than before incubation (IC50 = 4.5 µM) (Zhao et al., 2009). Peptides RIGLF, 
AHEPVK, and PSSNK from button mushroom (Agaricus bisporus) exhibited an 
increase in ACE inhibitiory activity to 90% from approximately 63-80%, after gastric 
digestion (Lau, Abdullah, Shui, and Aminudin, 2014). Typically, true inhibitors and 
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pro-drugs are recommended as they possibly exhibit the antihypertensive effect         
in vivo, while the substrate type is likely to be less effective (Ahhmed and Muguruma, 
2010). 
 
 
 
 
 
 
 
 
39 
 
Table 2.1 Angiotensin I converting enzyme inhibitory peptides derived from food proteins. 
 
Protein sources Enzymes Peptide sequences  IC50 References 
Plants     
   Rapeseed meal Subtilisin RIY 28 µM Marczak et al. (2003) 
  VWIS 30 µM  
 Alcalase LY 0.11 mM He et al. (2013) 
   Rapeseed albumin Alcalase PFDSYFVC 0.2 mg/mL Yu et al. (2013) 
   Canola meal Alcalase VSV 0.2 µM Wu, Aluko, and Muir (2008) 
     FL 1.3 µM  
   Rice Alcalase VNP 6.4 µM Chen et al. (2013) 
  VWP 4.5 µM  
   Soy bean Thermolysin IVF < 10 µM Gu and Wu (2013) 
  LLF < 10 µM  
  LNF < 10 µM  
  LSW < 10 µM  
  LEF < 10 µM  
   Red bean Alcalase  papain PVNNPQIH 206.7 µM Rui, Boye, Simpson, and 
Prasher (2013) 
3
9
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Table 2.1 Angiotensin I converting enzyme inhibitory peptides derived from food proteins (Continued).  
 
Protein sources Enzymes Peptide sequences    IC50 References 
Plants (continued)     
   Wheat gluten Trypsin IPALLKR 43 µM Asoodeh et al. (2014) 
  AQQLAAQLPAMCR 68 µM  
   Pistachio Trypsin  pepsin ACKEP 126 µM Li et al. (2014) 
   Brewers’ spent grain Alcalase IVY 80.4 µM Connolly, O’Keeffe, Piggott, 
Nongonierma,  and FitGerald 
(2015) 
 
  ILDL 96.4 µM 
   Soya milk PROTIN SD-NY10  FFVY 1.9 µM Tomatsu et al. (2013) 
  WHP 4.8 µM 
  FVP 10.1 µM 
  LHPGDAQR 10.3 µM 
  IAV 27.0 µM 
     VNP 32.5 µM 
  LEPP 100.1 µM 
  WNPR 880 µM 
4
0
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Table 2.1 Angiotensin I converting enzyme inhibitory peptides derived from food proteins (Continued).  
 
Protein sources Enzymes Peptide sequences   IC50 References 
Animals      
   Porcine myosin heavy chain Thermolysin MNPPK 945.5 µM Arihara, Nakashima, Mukai, 
Ishikawa, and Itoh (2001)      ITTNP 549.0 µM 
   Porcine myosin B Pepsin KRVIQY 6.1 µM Muguruma et al. (2009) 
     VKAGF 20.3 µM 
   Chicken muscle Thermolysin LKA 8.5 µM Fujita, Eiichiyokoyama, and 
Yoshikawa (2000)   LKP 0.3 µM 
  LAP 3.5 µM 
  FQKPKR 14 µM 
  IVGRPRHQG 2.4 µM 
  FKGRYYP 0.6 µM 
  IKW 0.2 µM 
   Bullfrog Alcalase GAAQLPCSADWW 1.0 µM Qian, Jung, Lee, Byun, and  
Kim (2007)     
   Porcine hemoglobin Pepsin LGFPTTKTYFPHF 4.9 µM Yu et al. (2006) 
     VVYPWT 6.0 µM 
   Yak milk β-casein Alcalase PLPLL 0.3 µM Mao, Ni, Sun, Hao, and Fan  
(2007)     
4
1
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Table 2.1 Angiotensin I converting enzyme inhibitory peptides derived from food proteins (Continued).  
 
Protein sources Enzymes Peptide sequences   IC50 References 
Animal products     
   β -Casein of donkey’s milk Pepsin  pancreatin VAPFPQPVVP 273 µM Bidasolo, Ramos, and Gomez-
Ruiz (2012)     
   β-Lactoglobulin Trypsin IIAEK 63.7 µM Power, Fernández, Norris, 
Riera, and FitzGerald (2014)   IPAVFK 144.8 µM 
  ALPMHIR 42.6 µM Ferreiraa et al. (2007) 
    Protease N Amano SAPLRVY 8 µM Ortiz-Chao et al. (2009) 
   Buffalo colostrum  Trypsin IIAMK 498 µM Rohit, Sathisha, and Aparna 
(2012)     
   Bovine lactoferrin Pepsin LIWKL 0.5 µM Ruiz-Giménez et al. (2012) 
  RPYL 56.5 µM 
  LNNSRAP 105.3 µM 
   κ-Casein 
AS1.398 neutral 
protease 
RYPSYG 54 µM 
Jiang, Tian, Brodkorb, and 
Huo (2010) 
   Yak milk κ-casein Alcalase PPQIN 0.3 µM 
   α-Casein Subtilisin MKP 0.3 µM Yamada et al. (2013) 
   β-Casein Protease from 
Lactobacillus  
TP 440 µM Stressler, Eisele, and Fischer 
(2013)    
4
2
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Table 2.1 Angiotensin I converting enzyme inhibitory peptides derived from food proteins (Continued).  
 
Protein sources Enzymes Peptide sequences IC50 References 
Animal products (continued)    
β-Casein helveticus ATCC 15009 MP 515 µM Stressler, Eisele, and 
Fischer (2013)   LP 5.7 mM 
  DQRF 21 µM 
   Egg white Alcalase TNGIIR 70 µM Yu et al. (2012) 
   Egg white Protease from fig-leaf  SWVE 33.9 µM Pokora et al. (2014) 
    gourd fruit DILN 73.4 µM  
   Overtransferrin Thermolysin  pepsin IQW 1.5 µM Majumder and Wu (2011) 
  IRW 0.6 µM  
  LKP 2.9 µM  
   Ovalbumin Pepsin FGRCVSP 6.2 µM Fujita et al. (2000) 
  ERKIKVYL 1.2 µM  
  FFGRCVSP 0.4 µM  
  LW 6.8 µM  
  FCF 11 µM  
  NIFYCP 15 µM  
   Hen egg white lysozyme Gastrointestinal proteases MKR 25.7 µM Rao et al. (2012) 
4
3
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Table 2.1 Angiotensin I converting enzyme inhibitory peptides derived from food proteins (Continued). 
 
Protein sources Enzymes Peptide sequences      IC50         References 
Animal products (continued)    
   Hen egg white lysozyme Gastrointestinal proteases RGY 61.9 µM Rao et al. (2012) 
  VAW 2.9 µM 
    Papain  trypsin FQSNFNTQATNR 30 µg/mL Asoodeh, Yazdi, and 
Chamani (2012)     
   Egg yolk Asian pumpkin protease LAPSLPGKPKPD 2.0 µM Eckert et al. (2014) 
   Ostrich egg white Trypsin AFKDQDTQQVPFR 80.2 µM Tanzadehpanah, Asoodeh, 
Saberi, and Chamani (2013)     
   Shark meat Protease SM98011 CF 2.0 µM Wu et al. (2008) 
  QT 2.7 µM 
  MF 1.5 µM 
   Seaweed pipefish Alcalase TFPHGP 0.6 µM Wijesekara, Qian, Ryu, 
Ngo, and Kim (2011)   HWTTQR 1.4 µM 
   Haruan myofibrillar Thermolysin VPAAPPK 0.5 µM Ghassem, Arihara, Babji, 
Said, and Ibrahim (2011)   NGTWFEPP 0.6 µM 
   Grass carp Alcalase VAP 5.3 µg/mL Chen, Wang, Zhong, Wu, 
and Xia (2012)     
4
4
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Table 2.1 Angiotensin I converting enzyme inhibitory peptides derived from food proteins (Continued).  
 
Protein sources Enzymes Peptide sequences IC50          References 
Fish and fish products (Continued)    
   Travelly Bromelain AR 570.8 µM Salampessy, Reddy, 
Kailasapathy, and Phillips 
(2015) 
  AV 956.3 µM 
  APER 530.2 µM 
   Lizard Neutral protease RVCLP 175 µM Wu, Feng, Lan, Xu, and 
Liao (2015)     
   Dried bonito Thermolysin LKPNM 2.4 µM 
   Bigeye tuna muscle Pepsin WPQAAQLMMQVDP  21.6 Qian, Je, and Kim         
(2007)     
   Chum salmon skin Trypsin GLPLNLP 18.7 µM Lee, Jeon, and Byun (2014) 
   Skate skin α-Chymotrypsin PGPLGLTGP 95 µM Lee, Jeon, and Byun (2011) 
  QLGFLGPR 148 µM 
   Atlantic salmon collagen Alcalase  papain AP 60 µM 
Gu, Li, Liu, Yi, and Cai 
(2011) 
  VR 33.2 µM  
   Alaska pollack skins 
gelatin 
Alcalase  pronase E  
 collagenase 
GPL 2.6 µM Byun and Kim (2001) 
4
5
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Table 2.1 Angiotensin I converting enzyme inhibitory peptides derived from food proteins (Continued).  
 
Protein sources Enzymes Peptide sequences  IC50 References 
Fish and fish products (Continued)    
   Alaska pollack skins gelatin Alcalase  pronase E    
 collagenase 
GPM 17.1 µM Byun and Kim 
(2001) 
   Cod skin gelatin Papain TCSP 81% /0.5 mg/mL Ngo, Ryu, Vo, 
Himaya, and Kim  
(2011) 
  TGGGNV 68% /0.5 mg/mL 
   Pacific cod skin gelatin Gastrointestinal proteases LLMLDNDLPP 35.7 µM Himaya, Ngo, Ryu, 
and Kim (2012) 
   Skate skin gelatin Alcalase MVGSAPGVL 3.1 µM Ngo, Ryu, and Kim 
(2014) 
 
  LGPLGHQ 4.2 µM 
   Salmon pectoral fin Alcalase VWDPPKFD 9.1 µM Ahn, Jeon, Kim, 
and Je (2012)   FQDYVPLSCF 10.8 µM 
  FNVPLTQ 7.2 µM 
   Alaska pollock frame Trypsin NGMTY 39.2%/20 µg/mL Hou et al. (2012) 
  NGLAP 33%/20 µg/mL  
  WT 31.4%/20 µg/mL  
4
6
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Table 2.1 Angiotensin I converting enzyme inhibitory peptides derived from food proteins (Continued).  
Protein sources Enzymes Peptide sequences IC50 References 
Fish and fish products (Continued)    
   Tuna frame Pepsin GDLGKTTTVSNWSPPKYLDTP 11.3 µM Lee, Qian, and Kim 
(2010) 
   Skipjack roe Alcalase FVSACSVAG 3.5 µM Intarasirisawat, 
Benjakul, Wu, and  
  DWMKGQ 422.9 µM Visessanguan (2013) 
  LADGVAAPA 317.8 µM  
  YVNDAATLLPR 105.9 µM  
  DLDLRKDLYAN 67.4 µM  
  MCYPAST 58.7 µM  
  MLVFAV 3.1 µM  
Other sources     
   Rotifer    Alcalase DDTGHDFQDTGQAM 9.6 µM Lee, Hong, Jeon, Kim, 
and Byun (2009) 
   Insect Alcalase AVP, VF 320 µg/mL Vercruysse et al. (2010) 
   Cuttlefish Digestive protease of 
cuttle fish 
VTAP 6.1 µM Balti, Nedjar-Arroume,  
Bougatef, Guillochon, 
and  Nasri (2010) 
VIIF 8.7%/20 µg/mL 
4
7
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Table 2.1 Angiotensin I converting enzyme inhibitory peptides derived from food proteins (Continued).  
 
 
 
Protein sources Enzymes Peptide sequences IC50 References 
Fish and fish products (Continued)    
   Cuttlefish Digestive protease of cuttle fish MAW 16.3%/20 µg/mL Balti, Nedjar-Arroume,  
Bougatef, Guillochon, 
and  Nasri (2010) 
   Microalgae Alcalase VQGY 128.4 µM Koa et al. (2012) 
   Algae protein waste Pepsin VQCYGPNRPQF 29.6 µM Sheih, Fang, and Wu 
(2009) 
   Silkworm pupa Alcalase KHV 12.8 µM Jia, Wu, Yan, and Gui 
(2015) 
   Sipunculid worm Pepsin AWLHPGAPKVF 135 M Dub et al. (2013) 
   Cotton leafworm Pepsin  trypsin  pancreatin AVF 2123 µM Vercruysse, Smagghe, 
Matsui, and Camp 
(2008) 
4
8
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CHAPTER III 
MATERIALS AND METHODS 
 
3.1 Materials 
 Thai Panga (Pangasius hypopthalmus  P. bocourti) skins were obtained from 
Nakhon Phanom Fisheries Office, Department of Fisheries, Thailand. Samples were 
kept in a polystyrene foam box filled with ice and transported to the laboratory at 
Suranaree University of Technology. Upon arrival, fish skins were cleaned and dried 
at 60
o
C for 12 h and cut into pieces (0.5 × 0.5 cm). The dried samples were packed in 
the vacuum bag and kept at -20
o
C until use. Alcalase 2.4L, Protamex was provided by 
Novozymes (Bagsvaerd, Denmark). Papain, pepsin, pancreatin, angiotensin-I-
converting enzyme (ACE) from rabbit lung, hippuryl-L histidyl-L-leucine (HHL), and 
2,4,6-trinitrobenzenesulfonic acid (TNBS) were purchased from Sigma Chemical Co. 
(St. Louis, MO, USA). Hippuric acid (HA) was obtained from Aldrich (Sigma-
Aldrich Chemie GmbH, Steinheim, Germany). Acetonitrile with high performance 
liquid chromatograohy (HPLC) grade was purchased from Merck (Merck KGaA, 
Darmstadt, Germany). Trifluoroacetic acid (TFA) was purchased from Supelco 
(Bellefonte, PA, USA). Other chemicals and reagents used were of analytical grade. 
 
3.2 Virgibacillus halodenitrificans SK 1-3-7 protease production 
Virgibacillus halodenitrificans SK 1-3-7 protease was produced according to 
the method as described by Montriwong et al. (2012). A loopful of pure culture was 
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transferred from JCM 168 agar (0.5% yeast extract, 0.5% casamino acid, 0.1% sodium 
glutamate, 0.3% trisodium citrate, 0.02% KCl, 2% MgSO4, 0.0036% FeCl24H2O, 
0.0036% MnCl24H2O and 5% NaCl) into Ym broth (1% yeast extract, 0.3% trisodium 
citrate, 0.2% potassium chloride, 2.5% magnesium sulfate) containing 2.5% NaCl and 
incubated at 35
o
C for 3 days. The inoculum was diluted to obtain optical density (OD) 
of 0.1 at 600 nm (approximately 10
7 
CFU/mL). Fifty milliliters of diluted inoculum 
was transferred to a 2-L flask containing 450 mL of YM broth and incubated at 35
o
C 
for 5 days at a shaking speed of 100 rpm. Cell-free supernatants were collected by 
centrifugation at 10,000g, 4oC for 20 min and lyophilized. The lyophilized powder 
was referred to as crude enzyme. Protease activity was assayed using azocasein as a 
substrate. One unit activity was defined as the amount of enzyme that increased OD450 
of 0.01 per min at pH 9.0, 60
o
C for 60 min. 
 
3.3 Protein substrate preparations 
Fish skins were defatted by soaking skins (0.5  0.5 cm) in 10% butyl alcohol 
with the ratio of skin to solvent of 1 : 10 (w/v) at 4
o
C for 24 h with a continuous 
stirring and the solvent was changed every 3 h. Subsequently, skins were washed with 
tap water for 30 min followed by reverse osmosis (RO) water for 3 times. The washed 
skins were left in a hood at room temperature for 1 h. The defatted skins were 
lyophilized and ground at 4
o
C with a set speed of 20,000 rpm using IKA milling 
machine (IKA M20, IKA-Werke GmbHandCo, Staufen, Germany) and kept at -20
o
C 
until use. 
Alkaline-acid pretreated skins were prepared according to the method of 
Jongjareonrak et al. (2010) with slight modifications. Skins were soaked in 0.1 N 
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NaOH with the ratio of 1 : 20 (w/v) for 24 h. The alkaline-acid treated skins were then 
washed with tap water until neutral pH was obtained. The skins were then soaked in 
10% butyl alcohol at the ratio of 1 : 10 (w/v) for 12 h and continuously rinsed in tap 
water for 30 min. Subsequently, skins were soaked in 0.05 M acetic acid at a ratio of  
1 : 20 (w/v) at 4
o
C for 12 h and washed with tap water until pH of wash water was 
neutral, followed by washing with RO water for 3 times. All soaking steps were 
carried out at 4
o
C with continuous stirring and changing the solution every 3 h. The 
skins were lyophilized, ground, and stored as described above.   
Gelatin was extracted by gentle stirring the alkaline-acid pretreated skins in 
deionized (DI) water with skins/water ratio of 1 : 10 (w/v) at 45
o
C for 12 h. The 
viscous solutions were centrifuged at 10,000g, 4oC for 30 min. The supernatants 
were collected as gelatin solution, lyophilized, and ground at 4
o
C with a set speed of 
20,000 rpm using IKA milling machine (IKA M20, IKA-Werke GmbHandCo, 
Staufen, Germany) and kept at -20
o
C until used. 
 
3.4 Chemical composition of protein substrates 
3.4.1 Proximate analyses 
 Moisture, crude fat, crude protein and ash content of dried skin, dried defatted 
skin, dried pretreated skin and dried gelatin were determined according to AOAC 
(2000). 
3.4.2 Amino acid composition 
According to AOAC (2000), powders of all skin samples (0.05-0.1 g) were 
hydrolyzed with 6 N HCl-phenol at 110
o
C for 24 h, while, cysteine and methionine 
contents were determined using performic acid oxidation with acid hydrolysis-sodium 
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metabisulfite method. The tryptophan content was determined following AOAC 
(2006) by alkaline hydrolysis. Quantitative analysis of total amino acids was achieved 
by a Biochrom 30 amino acid analyzer (Biochrom Ltd., Cambridge Science Park, 
England). Stepwise elution gradient was performed using lithium loading buffer pH 
2.20, 2.80, 3.00, 3.15, 3.50, 3.55, and 6 (Biochrom Ltd., Cambridge Science Park, 
England). Peaks of amino acid residues were detected at 570 nm and at 440 nm for 
proline using amino acid standards for protein hydrolysates as an external standard 
(Sigma-Aldrich Chemie GmbH, Steinheim, Germany). The amino acid was expressed 
as g/100g protein. 
3.4.3 SDS-PAGE pattern 
All dried samples were dissolved in 5% SDS with skin to SDS ratio of 0.1 : 10 
(w/v). The suspensions were homogenized using an IKA hand homogenizer (IKA 
Works Asia, Bhd, Malaysia) for 10 min and heated at 90
o
C for 10 min. The mixtures 
were then centrifuged at 10,000g, 25oC for 20 min. The supernatants were collected 
and then 2-folds concentrated loading buffer containing β-mercaptoethanol was added. 
The samples were heat at 90
o
C for 3 min and SDS-PAGE was performed according to 
Laemmli (1970). Samples (25 µg) were loaded onto 7.5% acrylamide gel. Gels were 
run at a constant voltage at 120 V, stained with 0.125% Comassie Brilliant blue R-250 
and destained in a solution containing 25% ethanol and 10% acetic acid.  
 
3.5 Production of Thai Panga skin hydrolysates 
To determine the optimal substrate and protease, 9 mL of DI water were added 
into 0.1 g protein of each sample (defatted skin, alkaline-acid pretreated skin and 
gelatin powder). The suspension was adjusted pH and pre-incubated in a shaking 
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water bath for 5 min under the optimal condition of protease applied: pH 8, 55
o
C for 
Alcalase; pH 2, 37
o
C for pepsin; pH 8, 37
o
C for trypsin; pH 7, 55
o
C for papain; pH 
7.5, 55
o
C for Protamex; and pH 8, 60
o
C for protease from Virgibacillus 
halodenitrificans SK 1-3-7. Protein hydrolysis was carried out at enzyme to substrate 
ratio of 1 : 100 (w/w) for all commercial proteases. V. halodenitrificans SK 1-3-7 
protease was added to the reaction mixture at a final unit activity of 2.5 U. Samples 
were hydrolyzed for 12 h and then heated at 95
o
C for 10 min to terminate the reaction. 
The samples were centrifuged at 10,000g, 4oC for 20 min. Samples were adjusted to 
pH 7 using 10 N NaOH or 6 N HCl. The supernatants were referred to as crude 
hydrolysates and used for ACE inhibitory activity assay. 
 As alkaline-acid pretreated skin and pepsin showed the highest ACE inhibitory 
activity, the effect of hydrolysis time on ACE inhibitory activity was studied. 
Alkaline-acid pretreated skin powder was added DI water (10% w/v) and adjusted to 
pH 2. The mixtures were pre-incubated at 37oC for 5 min. The samples were then 
added pepsin with the enzyme/substrate ratio of 1:100 (w/w). The samples were taken 
for the measurement of degree of hydrolysis (DH) and ACE inhibitory activity at 
various time intervals of  0, 2, 4, 8, and 12 h. Samples at each time interval were 
heated at 95oC for 10 min to terminate the reaction and centrifuged 10,000  g at 4oC 
for 20 min.  
 
3.6 Degree of hydrolysis (DH) 
 DH was determined according to Adler-Nissen (1979). Fifty microliters of 
hydrolysates was mixed with 0.5 mL of 0.2125 M phosphate buffer, pH 8.2 and 0.5 
mL of 0.05% TNBS reagent. The mixture was incubated at 50
o
C for 1 h. The reactions 
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were terminated by adding 0.1 N HCl and then left at room temperature for 30 min. 
Absorbance was monitored at 420 nm using glycine which is a major amino acid in 
skins of Thai Panga as a standard. To determine total amino acid content, dried 
powder of all samples was hydrolyzed with 6 N HCl at a ratio of 1 : 100 at 120
o
C for 
24 h using an autoclave. The degree of hydrolysis was calculated as follow: 
 
    DH (%) =     
 
where hs is α-amino group content of sample at time t, h0 is α-amino content of 
sample at 0 h, and ht is the total α-amino content obtained after acid hydrolysis. 
 
3.7 ACE inhibitory activity assay 
 The in vitro assay was determined according to Cushman and Cheng (1971) 
with slight modifications. Protein hydrolysates (50 µL) and 150 µL of ACE substrate 
(8.3 mM HHL in 50 mM sodium borate buffer containing 0.5 M NaCl, pH 8.3) were 
pre-incubated at 37
o
C for 10 min. Then, 50 µL of 25 mU/mL of ACE was added and 
reaction was incubated at 37
o
C for 60 min in a shaking water bath with a set speed of 
180 rpm. The reaction was terminated by adding 250 µL of 1 N HCl. Hippuric acid 
(HA) was extracted with 1.5 mL ethyl acetate. After centrifugation at 800g, 4oC for 
15 min, 1 mL of the supernatant was transferred into a test tube and solvent was 
evaporated at 80
o
C on a sand bath. The dried samples were re-dissolved in 1 mL of DI 
water and filtered through a 0.45-µm membrane filter before subjected to HPLC (1260 
Infinity, Multiple Wavelength Detector, Agilent Technologies, Santa Clara, CA, 
USA). Twenty µL of samples were injected into a Zorbax Eclipse XDB-C18 column 
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(4.6  150 mm, Agilent Technologies, Santa Clara, CA, USA). The column was 
eluted with a mobile phase A of 0.05% TFA in DI water and mobile phase B of 0.05% 
TFA in acetonitrile at a flow rate of 0.5 mL/min. The separation condition was 
performed with 0-60% B for the first 10 min, maintained at 60% B for 2 min, 
subsequently returned to 5% B for 1 min and maintained at 5% B for 5 min. The 
chromatogram was monitored at 228 nm and HA was used as an external standard. 
Blanks were performed by adding 0.1 N HCl prior to ACE. The ACE inhibitory 
activity (%) was calculated following the equation: 
 
ACE inhibitory activity (%)  = 
 
where C0 is HA content in the control (without protein hydrolysates), CB is HA 
content in the control blank (without protein hydrolysates), I0 is HA content in the 
sample in the presence of protein hydrolysates, and IB is HA content of blank in the 
presence of protein hydrolysates.  
 
3.8 Purification of ACE inhibitory peptides 
3.8.1 Ultrafiltration 
Pepsin-hydrolyzed alkaline-acid pretreated skin which showed the highest 
ACE inhibitory activity was selected for further purification. The sample was firstly 
subjected to the sequential ultrafiltration fractionation using 5-L Ultralab System 
(PALL Corporation, Ann Arbor, MI, USA). Crude hydrolysate (1L) was passed  
through a 30-kDa molecular weight cut-off (MWCO) membrane (PALL Corporation, 
Ann Arbor, MI, USA), the retentate  was collected for ACE inhibitory activity and 
TNBS  determination, while  permeate  was  fractionated sequentially through a 5-kDa 
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and 1-kDa MWCO membrane (PALL Corporation, Ann Arbor, MI, USA). The 
permeate and retentate fractions obtained from each  membrane were also collected 
for ACE inhibitory activity and TNBS detemination. The fraction exhibiting the 
highest ACE inhibitory activity was subjected to ion exchange chromatography. 
3.8.2 Ion exchange chromatography 
The purification was performed using AKTA Purifier FPLC with UNICORN 
software version 5.01 (GE Healthcare, Piscataway, NJ, USA). DEAE-Sephacel (GE 
Healthcare, Piscataway, NJ, USA) was packed in a column (2.6 × 6.5 cm) and 
equilibrated with 50 mM Tris-HCl buffer (pH 8.0). The lyophilized fraction of 
hydrolysate with MW < 1-kDa (100 mg) was dissolved in 1 mL of DI water, then 
filtered through a 0.45-µm membrane and subsequently loaded into the column. The 
column was washed with 0.05 M Tris-HCl for 35 mL and eluted with a linear gradient 
of NaCl (0-1.0 M). The elution was performed at a flow rate of 1 mL/min and 5-mL 
fractions were collected. The absorbance was monitored at 215 nm. ACE inhibitory 
activity and peptide content were determined. The fraction showing the highest ACE 
inhibitory activity was lyophillized and collected for size exclusion chromatography.  
3.8.3 Size exclusion chromatography 
The lyophilized powder obtained from 3.8.2 was dissolved in DI water (100 
mg/mL). A hundred µL of peptide solution was loaded into a Superdex Peptide 
10/300 GL column (10 mm × 300 mm; GE Healthcare, Piscataway, NJ, USA) pre-
equilibrated with DI water. The elution was performed using AKTA purifier (GE 
Healthcare, Piscataway, NJ, USA) at a flow rate of 0.2 mL/min and absorbance was 
monitored at 215 nm. Fractions (1 mL) were collected and determined for ACE 
inhibition and peptide content. The fraction with the highest ACE inhibitory activity 
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was used for IC50 determination. In vitro pepsin-pancreatin simulated gastrointestinal 
(GI) digestion was also evaluated.  
For IC50 determination, peptides at various concentrations of 1.25, 2.5, 5.0, 
10.0, 25.0, 50.0 µg Gly eq./mL were prepared and determined for ACE inhibitory 
activity.  IC50 value defined as the concentration of peptide at which 50% inhibition is 
attained was calculated using GraphPad

 Prism 6.0.  
3.8.4 Peptide identification  
 The potent fraction obtained from a Superdex Peptide 10/300 GL column was 
analyzed for de novo peptide sequencing using a Waters SYNAPT™ HDMS™ 
system. The 1D-nanoLC was carried out with a Waters nanoACQUITY UPLC 
system.  Four µL of digests was injected onto the RP analytical column (20 cm × 75 
μm) packed with a 1.7 μm Bridged Ethyl Hybrid (BEH) C18 (Waters Corporation, 
MA, USA).  Peptides were eluted with a linear gradient from 2% to 40% acetonitrile 
developed over 60 min at a flow rate of 350 nL/min.  This was followed by a 15 min 
period of 80% acetonitrile to clean the column before returning to 2% acetonitrile for 
the next sample.  The effluent samples were electrosprayed into a mass spectrometer 
(Synapt HDMS) for MS/MS analysis of peptides. Argon gas was used in the collision 
cell to obtain MS/MS data. MS/MS spectra thus obtained were processed using Max 
Ent 3, a deconvolution software for peptides (Ensemble 1, Iterations 50, auto peak 
width determination) within MassLynx 4.0. The deconvoluted spectra were then 
imported into Mass Seq (MassLynx's denovo sequencing tool) to obtain a sequence 
tag. 
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3.9 In vitro pepsin-pancreatin simulated GI digestion 
Simulated GI digestion using an in vitro pepsin-pancreatin hydrolysis was 
performed according to Rao et al. (2012) with some modifications. The partially 
purified peptides from Superdex Peptide 10/300 GL column (60 µg. Gly eq./mL) were 
lyophilized. Peptide powder was re-dissolved with 2.2 mL DI water, pH 2 and pre-
incubated at 37
o
C for 5 min.  Pepsin (concentration 1.2 µg/mL, 0.5 mL) was added to 
provide enzyme to substrate ratio of 1:100 (w/w). The mixture were incubated at 37
o
C 
for 3 h and then adjusted to pH 7.5 with 10 N NaOH. The mixture volume was 
adjusted to 2.9 mL. Neutralized mixture (0.3 mL) was collected and centrifuged at 
10,000  g for 10 min. The supernatant was collected for determination of α-amino 
acid group content and ACE inhibitory activity.  The suspension was further digested 
by 2% (w/w) porcine pancreatin at 37
o
C for 4 h. The digestion was terminated at 90
o
C 
for 10 min and centrifuged at 10,000  g for 10 min. The supernatant was collected to 
determine α-amino acid group content and ACE inhibitory activity. 
 
3.10 Statistical analyses 
 All experiments were repeated twice. Measurements were carried out in a 
duplication. Data (n = 4) were expressed as mean ± standard deviation. The statistical 
analysis was performed using SPSS Statistics Program (Version 17.0, SPSS Inc, 
Chicago, IL, USA). Data were analyzed using analysis of variance (ANOVA). 
Duncan’s multiple range test (DMRT) was used in a mean comparison at a statistical 
level as P-value < 0.05. 
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CHAPTER IV 
RESULTS AND DISCUSSION 
 
4.1 Chemical characteristics of skin and gelatin  
 4.1.1 Proximate composition 
The proximate composition of various forms of skin and gelatin was 
summarized in Table 4.1. Protein is a major component in Thai Panga skin. Protein 
content is higher than skins of fish without scale including bamboo shark skin (65.1%) 
(Kittiphattanabawon, Benjakul, Visessanguan, Kishimura, and Shahidi, 2010) and 
shortfin scad skin (60.9%) (Cheow, Norizah, Kyaw, and Howell, 2007) but lower than 
the skin of walking catfish (82.6%) (Jamilah, Tan, Hartina, and Azizah, 2011), striped 
catfish (85.4%) (Jamilah, Tan, Hartina, and Azizah, 2011), and channel catfish 
(76.8%) (Liu, Li, and Guo, 2007). High amount of protein indicated that Thai Panga 
can be a good source for the bioactive peptide production. The skin also contained 
relatively higher fat than those previously reported which were in range of 0.5-24.3% 
(Cheow, Norizah, Kyaw, and Howell, 2007; Kittiphattanabawon, Benjakul, 
Visessanguan, Kishimura, and Shahidi, 2010; Liu, Li, and Guo, 2007). Skin of Thai 
Panga contain trace amount of ash. Ash content of striped catfish was 11.7% and 
walking catfish was 1.4% (Jamilah, Tan, Hartina, and Azizah, 2011). 
 Butyl alcohol extraction and alkaline-acid pretreatment only removed about 
36.2% fat from the skin. Fat was removed up to 70% after thermal hydrolysis into 
gelatin. However, it is relatively high when compared with that of other fish skin 
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gelatins (< 1.0%) (Binsi, Shamasundar, Dileep, Badii, and Howell, 2009; Cheow, 
Norizah, Kyaw, and Howell, 2007; Jellouli et al., 2011; Jongjareonrak et al., 2010; 
Lassoued et al., 2014). These results reflect that pretreatment condition was not 
efficient to remove fat from Thai Panga skin. High polarity of buthanol may cause 
insufficient removal of fat. In general, commercial gelatin contain 84-90% protein 
with free of fat and containing ash lower than 2% (Gelatine Manufacturers of Europe, 
2015).  
 
Table 4.1 Chemical compositions (% dry basis) of dried skin, defatted skin, alkaline-
acid pretreated skin and gelatin of Thai Panga. 
  
Note: Values are expressed as mean ± SD (n = 4). Superscript indicates a significant 
difference of skin pre-treatment at P<0.05. 
 
 4.1.2 Protein patterns 
Main protein component of all samples is collagen as seen on SDS-PAGE 
(Figure 4.1). Defatted and alkaline-acid pretreated skin contained β-component (MW 
~200 kDa), α1 and α2 chain (MW ~100 kDa) as major constituents which were 
similar to the pattern of bovine tendon type I collagen (TC). High molecular mass 
component (MW > 200 kDa), which are intra- and intermolecular crosslinks of 
collagen were also observed. However, low molecular mass components (MW ~100 
Compositions Skin Defatted skin 
Alkaline-acid 
pretreated skin 
Gelatin 
  Crude protein 71.4
c
 81.9
b
 85.2
b
 91.8
a
 
  Crude fat 28.4
a
 18.1
b
 14.8
b
 8.1
c
 
  Ash 0.3
a
 0.1
b
 0.0
c
 0.0
c
 
 
 
 
 
 
 
 
 
61 
 
200 kDa 
116 kDa 
97 kDa  
45 kDa 
31 kDa 
    STD         DS       PS       TPG  TC 
γ 
β 
α2 
α1 
Da) did not appear in all skins. Intensity of β-component of gelatin is lighter than 
others. The band of α2-chain of gelatin disappeared with a concomitant formation of 
the low molecular mass peptides (MW ~31 kDa). These were possibly due to the 
transition of the collagen triple helix to coil structure and some peptide bonds 
cleavage induced by thermal extraction. This phenomenon has been reported in fish 
gelatin extracted at temperature higher than 45
o
C (Kittiphattanabawon, Benjakul, 
Visessanguan, and Shahidi, 2010; Muyonga, Cole, and Duodu, 2004; Nagarajan, 
Benjakul, Prodpran, Songtipya, and Kishimura, 2012; Sinthusamran, Benjakul, and 
Kishimura, 2014) 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1 SDS-PAGE pattern (7.5% polyacrylamide) of a standard marker (STD),          
defatted skin (DS), alkalie-acid pretreated skin (PS), gelatin (TPG) of 
Thai Panga, and type I tendon collagen (TC). 
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 4.1.3 Amino acid composition 
          Amino acid compositions are a critical factor providing bioactivity of peptides. 
The amino acid compositions of all samples were shown in Table 4.2. The most 
abundant amino acids in all samples are Gly, Pro, Hyp, Arg, Ala, Glu/Gln. In general, 
Gly exists uniformly in the α-chain as a repeating formula Gly-X-Y (X and Y is 
mainly Pro and Hyp, respectively) throughout the collagen molecules (Asghar and 
Henrickson, 1982). Likewise, Ala, Pro and Hyp are usually found in collagen 
molecules, while Cys and Tyr are not common (Muyonga, Cole, and Duodu, 2004). In 
general, amino acid composition is not different among samples (P>0.05). High 
proportion of Gly, Ala, Pro, Glu/Gln and Arg were also observed in chum salmon, 
channel catfish, farmed Amur sturgeon and striped catfish skin (Lee, Jeon, and Byun, 
2014; Liu, Li, and Guo, 2007; Nikoo et al., 2014; Singh, Benjakul, Maqsood, and 
Kishimura, 2011). Amino acid contents of gelatin were in the range found in other fish 
species (19.6-37.6 g/100 g protein for Gly, 8.3-11.9 g. /100 g. protein for Ala,         
1.9-13.6 g/100 g protein for Pro, 3.3-10.5 g./100 g. protein for Glu/Gln, and 3.5-8.7 
g/100 g protein for Arg) (Binsi, Shamasundar, Dileep, Badii, and Howell, 2009; 
Cheow, Norizah, Kyaw, and Howell, 2007; Duan, Zhang, Xing, Konno, and Xu, 
2011; Jamilah, Tan, Hartin, and Azizah, 2011; Lee, Jeon, and Byun, 2014; Liu, Li, 
and Guo, 2007; Nagai, Araki, and Suzukia, 2002; Nikoo et al., 2014; Sila et al., 2015; 
Singh, Benjakul, Maqsood, and Kishimura, 2011; Zeng et al., 2009; Zhang et al., 
2007). The contents of Asp, Glu/Gln, and Ser of defatted and alkaline-acid pretreated 
skin are higher than those of gelatin (P<0.05). These amino acids possibly lost during 
the thermal extraction of gelatin. Alkaline-acid pretreated skin and gelatin had higher 
amount Pro than defatted skin (P<0.05). Removal of non-collagen substance by 
alkaline-acid pretreatment as well as thermal extraction leads to an increase in 
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collagen proportion, and higher amount of Pro in these two samples. Potent ACE 
inhibitory peptides found in previous studies usually contain Pro, Ala, Asp, Gly, Glu 
in their sequences (Table 2.1) such as protein hydrolysates from Rhopilema 
esculentum which contained high level of Gly, Glu, Pro, Asp and Ala (Liu, Zhang, 
Zhang, and Liu, 2012). Strong ACE inhibitory activity evidently associated with Pro 
residues in the peptide, particularly at the C-terminal position (Korhonen and Pihlanto, 
2006). Furthermore, peptides containing Pro is known to be resistant to the intestinal 
enzyme digestion and pass easily into the blood circulation (Walter, Kissel, and 
Amidon, 1996). Cushman and Ondetti (1984) proposed that Pro at C-terminal position 
of the peptides showed effective binding to ACE. In addition, most commercial ACE 
inhibitor drugs (Captopril and Enalapril) also contained Pro in their structure (Otte, 
Shalaby, Zakola, Pripp, and El-Shabrawy, 2007). Amino acid composition appeared to 
suggest that Thai Panga skin would contain the potent ACE inhibitory peptides. 
 
Table 4.2 Amino acids composition of defatted skins, pretreated skins and gelatin 
powder of Thai Panga (g/100 g protein). 
Amino acid Defatted skin Pretreated skin Gelatin 
    Alanine 8.6 8.1 7.6 
Arginine 8.7 
b
 9.3 
a
 8.3 
b
 
Aspartic acid/Asparagine 3.9 
a
 3.6 
a
 2.2 
b
 
Cysteine 3.1 1.2 3.7 
Glutamic acid/Glutamine 9.9 
a
 9.8 
a
 6.6 
b
 
Glycine 21.3 23.3 25.4 
Histidine 0.9 0.7 0.6 
Hydroxylysine ND ND ND 
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Table 4.2 Amino acids composition of defatted skins, pretreated skins and gelatin 
powder of Thai Panga (g/100 g protein) (Continued). 
Amino acid Defatted skin Pretreated skin Gelatin 
    Hydroxyproline 6.3 8.9 6.4 
Isoleucine 1.9 1.7 1.6 
Leucine 3.7 3.3 3.1 
Lysine 6.9 4.4 9.5 
Methionine 2.6 
a
 1.6 
b
 2.7 
a
 
Phenylalanine 1.9 1.8 2.1 
Proline 10.5 
b
 13.2
a
 12.6 
a
 
Serine 3.1 
a
 3.2 
a
 2.0 
b
 
Threonine 2.8 2.7 2.5 
Trptophan ND ND ND 
Tyrosine 0.9 0.5 0.5 
Valine 3.0 2.8 2.6 
    Total 100.00 100.00 100.00 
    
Data are expressed as mean ± SD (n = 2). 
 
4.2 Screening of substrate and protease for ACE inhibitory peptides 
production 
 Overall, there was a significant effect of enzyme on degree of hydrolysis (DH) 
(P<0.05).  The highest DH was found in hydrolysates prepared by Alcalase (P<0.05, 
Table 4.3). Alcalase is an endoprotease with broad specificity and high affinity toward 
aromatic amino acids, Glu, Met, Leu, Ala and Ser in the peptide chains (Barrett, 
Rawlings, and Woessner, 2004). Although Protamex, papain and V. halodenitrificans 
SK 1-3-7 protease have a broad specificity, they showed lower DH (P<0.05, Table 
4.4). Alcalase was recommended as the most effective enzyme in hydrolyzing 
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collagen (He, Liu, and Ma, 2013). It has been reported that skate skin hydrolysate by 
Alcalase showed higher DH (65.9%) than that of chymotrypsin (43.1%) and papain 
(45.4%) (Lee, Jeon, and Byun, 2011). It also showed relatively higher DH than that 
obtained from collagenase, Proteinase K, trypsin, thermolysin and pepsin in the 
hydrolysis of bovine collagen at the same hydrolysis time (Zhang, Olsen, Grossi, and 
Otte, 2013). Trypsin predominantly cleaves peptide bonds at carboxyl side of Lys and 
Arg (Barrett, Rawlings, and Woessner, 2004).  Rich Pro in the repeating sequence of 
Gly-Pro-Hyp in collagen probably obstructs the hydrolysis of trypsin. Pepsin 
preferably cleaves peptide bonds between hydrophobic and aromatic amino acids 
(Phe, Trp, and Tyr) (Barrett, Rawlings, and Woessner, 2004; Whitaker, 1994). Less 
content of these amino acids in collagen may limit pepsin hydrolysis. 
 It was observed that hydrolysates prepared at high temperature (50-60
o
C) 
showed higher DH than those produced at a low temperature (37
o
C for trypsin and 
pepsin) (P<0.05, Table 4.4). Thai Panga skin has a collagen as a major structural 
protein (Figure 4.1). This rigid structure is difficult to breakdown by a protease except 
for collagenase (Zhang, Olsen, Grossi, and Otte, 2013). However, it could be 
transformed to random coil of gelatin at 40
o
C (Karim and Bhat, 2009). When all 
substrates were subjected into the hydrolysis by Alcalase, V. halodenitrificans SK 1-3-
7 protease, Protamex, papain at temperatures above 50
o
C for 12 h, inter- and intra-
hydrogen bonds were likely to be disrupted. Particularly, heating collagen molecules 
in alkaline condition as in hydrolysis by Alcalase, papain, and V. halodenitrificans SK 
1-3-7 would weaken covalent crosslinks. The triple helical structure of collagen was 
uncoiled, converting to gelatin. This would, in turn, increase enzyme accessibility. 
Under pepsin and trypsin hydrolysis, which was performed in acidic and alkaline 
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condition at 37
o
C, respectively, the triple helix structure of collagen may partially 
uncoil, but covalent crosslinks among tropocollagen in the skin matrix remained, 
leading to the limited enzymatic hydrolysis, especially in defatted skin. 
 DH of gelatin was comparable to that of alkaline-acid pretreated skin (P>0.05, 
Table 4.4). Alkaline and acid pretreatment could open up the matrix structure of skin, 
allowing enzyme accessibility to the similar level as uncoiled structure of gelatin. On 
the other hand, gelatin showed DH value higher than defatted skin (P<0.05, Table 
4.4). This was because proteases could directly hydrolyze peptide bonds in individual 
random coil of gelatin easier than tightly packed matrix of collagen in defatted skin. 
Collagen in defatted skin is stabilized by numerous hydrogen bonds and covalent 
cross-links, leading to more protease resistance. Based on DH, Alcalase and defatted 
skin would be recommended to use to produce Thai Panga skin protein hydrolysate 
since a high yield would be obtained. 
 Type of protease and form of substrate have an overall effect on specific ACE 
inhibitory activity (P<0.05, Table 4.4). Pepsin hydrolysate showed the highest ACE 
inhibitory activity. Potency of ACE inhibitory peptides is strongly influenced by 
hydrophobicity of amino acid residues at the ultimate position of peptides since it has 
tightly bound at the sub-active site of ACE (Hong et al., 2008; Murray and FitzGerald, 
2007; Ondetti and Cushman, 1982). Pepsin may produce peptides with some 
hydrophobic amino acids at the C-terminal position, resulting in high ACE inhibitory 
activity. Protamex, papain, and Alcalase also produced hydrolysates with ACE 
inhibitory activity (Table 4.3). According to their broad specificity, the high amounts 
of small peptides were produced. The smaller peptides are well known to exhibit 
higher potent ACE inhibitory activity than the larger peptides since the latter is 
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hindered by the small cavity of ACE active site (Natesh, Schwager, Sturrock, and 
Acharya, 2003). For trypsin hydrolysate, ACE inhibitory potency was related to 
positively charged amino acid at C-terminal of peptides, which could interact with 
anionic binding site of ACE (FitzGerald and Meisel, 2000). The hydrolysate produced 
by V. halodenitrificans SK 1-3-7 protease showed lowest ACE inhibitory activity in 
this study. The ultimate position and length of peptides may not be favored for ACE 
active site. 
 ACE inhibitory activity also appears to vary with form of substrate. Alkaline-
acid pretreated skin hydrolysates showed ACE inhibitory activity higher than defatted 
skin and gelatin (P<0.05, Table 4.4). This might be due to the difference in amino acid 
composition among three substrates. Higher proportion of Pro and Arg (Table 4.2) in 
alkaline-acid pretreated skin may associate with its high specific ACE inhibitory 
activity. Interaction between substrate and enzyme used was significant (P<0.05).  
 Specific ACE inhibitory activity did not vary with form of substrate for 
Alcalase hydrolysis (P>0.05). Alcalase has been reported to degrade the triple helix of 
bovine collagen within a short time (Zhang, Olsen, Grossi, and Otte, 2013). Both 
defatted skin and alkaline-acid pretreated skin of Thai Panga were equally accessed by 
Alcalase. The collagen networks that were destabilized at 50
o
C could promote the 
accessibility of Alcalase to the skins, resulting in a similar specific ACE inhibitory 
activity.  
 Alkaline-acid pretreated skin and gelatin hydrolysate showed higher specific 
ACE inhibitory activity than defatted skin in pepsin hydrolysis (P<0.05, Table 4.3). At 
37
o
C, covalent cross-links of collagen fibrils in the defatted skin were still stabilized. 
Accessibility of pepsin to collagen in the defatted skin would be more difficult than in 
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alkaline-acid pretreated skin and gelatin. Collagen is a hydrophilic protein which can 
solubilize in polar solution (Shoulders and Raines, 2009). At pH 2, random coil 
gelatin and partially uncoiled collagen structure of alkaline-acid pretreated skin may 
ease them to be more solubilized in hydrochloric solution than a close packed 
structure of defatted skin. This would promote pepsin hydrolysis, leading to more 
release of ACE inhibitory peptides.  In addition, alkaline-acid pretreated skin and 
gelatin comprised of higher proportion Pro in their structure than defatted skin 
(P<0.05, Table 4.2). Strong ACE inhibitory activity evidently associated with Pro 
residues in the peptide, particularly at the C-terminal (Korhonen and Pihlanto, 2006). 
The most potent ACE inhibitory peptides with Pro at C-terminal produced by pepsin 
included Gly-Asp-Leu-Gly-Lys-Thr-Thr-Thr-Val-Ser-Pro-Pro-Lys-Tyr-Leu-Asp-Thr-
Pro derived from tuna frame hydrolysate (Lee, Qian, and Kim, 2010).  
 For trypsin hydrolysis, only the hydrolysate produced by alkaline-acid 
pretreated skin show specific ACE inhibitory activity (P<0.05, Table 4.3). Trypsin 
typically produces peptides with C-terminal Arg or Lys, whose guanidine or ε-amino 
can interact with an anionic binding site of ACE (Murray and FitzGerald, 2007). 
Peptides in trypsin-hydrolyzed gelatin and defatted skin hydrolysate may be devoid of 
these residues in their ultimate position, resulting in limited ACE inhibitory activity. 
Amino acid profile clearly showed that alkaline-acid pretreated skin has relatively 
higher proportion of Arg than others (P<0.05, Table 4.2). It could possibly be that 
alkaline-acid pretreated skin would release peptide containing Arg after trypsin 
hydrolysis, resulting in high specific ACE inhibitory activity. Several previous studies 
showed that the most potent ACE inhibitory peptides derived from trypsin 
hydrolysates of wheat gluten, β-lactoglobulin, buffalo colostrum, ostrich egg white, 
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chum salmon skin, and Alaska pollack frame contained peptide containing Arg at their 
C-terminal position (Asoodeh et al., 2014; Ferreiraa, et al., 2007; Hou et al., 2012; 
Lee, Jeon, and Byun, 2014; Rohit, Sathisha, and Aparna., 2012; Tanzadehpanah, 
Asoodeh, Saberi, and Chamani., 2013). 
 Specific ACE inhibitory activity of papain hydrolysate was also varied with 
form of substrate (P<0.05, Table 4.3). The highest specific ACE inhibitory activity 
was observed in papain-hydrolyzed alkaline-acid pretreated skin. It has been reported 
that the most potent ACE inhibitory peptides derived from cod skin and Atlantic 
salmon collagen hydrolysate was produced by papain hydrolysis, which contained Pro 
in their ultimate position (Gu, Li, Liu, Yi, and Cai., 2011; Ngo, Ryu, Voa, Himaya, 
and Kim, 2011). The cod skin peptide, Thr-Cys-Ser-Pro showed ACE inhibitory 
activity about 81% at 0.5 mg/mL, while a dipeptide, Ala-Pro, from Atlantic salmon 
collagen exhibited IC50 = 60 µM (Gu, Li, Liu, Yi, and Cai, 2011; Ngo, Ryu, Voa, 
Himaya, and Kim, 2011). High content of Pro in alkaline-acid pretreated skin (Table 
4.2) may provide the opportunity to release peptides with Pro at their C-terminal for 
papain hydrolysate, resulting in the highest ACE inhibitory activity.  
 Protamex hydrolysis of defatted and alkaline-acid pretreated skin showed 
higher specific ACE inhibitory activity than gelatin (P<0.05, Table 4.3). It has been 
found that a dipeptide, Tyr-Asn, derived from hard calm nuscle hydrolysate was the 
potent candidate in ACE inhibition with IC50 = 51 µM (Tsai, Chen, and Pan, 2008). 
High proportion of Asp/Asn in both defatted and alkaline-acid pretreated skin might 
generate some peptides rendering relatively high specific ACE inhibitory activity. 
 Specific ACE inhibitory activity of V. halodenitrificans SK 1-3-7 protease 
hydrolysis was only detected in alkaline-acid pretreated skin hydrolysate, while DH 
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and peptide content of all hydrolysates produced by this enzyme were comparable 
(P>0.05, Table 4.3). This suggested that peptide sequence was a critical factor for 
ACE inhibition. As reported by Toopcham, Roytrakul, and Yongsawatdigul (2015), 
the most potent ACE inhibitory peptide derived from tilapia hydrolysates composed of 
Arg at the C-terminal position (Met-Met-Leu-Leu-Leu-Phe-Arg, IC50 = 0.1 µM). High 
proportion of Arg in alkaline-acid pretreated skin may provide hydrolasate containing 
some peptides with C-terminal Arg, resulting in high specific ACE inhibitory activity. 
 These results imply that protease and form of substrate affected ACE 
inhibitory potency of Thai Panga skin hydrolysate. Protease governs the length and 
amino acid at the C-terminal end of peptide, while skin pretreatment contributed to 
improving the accessibility of protease to the substrate. The highest ACE inhibitory 
activity was detected in pepsin-hydrolyzed pretreated skins. Thus, pepsin and 
pretreated skin were selected for further studies.  
 Specific ACE inhibitory activity of hydrolysate did not follow the same trend 
as DH (P<0.05, Table 4.4). DH indicates the extent of protein degradation (Adler-
Nissen, 1979). Thus, single polypeptide chain of gelatin or opened collagen structure 
of alkaline-acid pretreated skin which was easily to cleave by the enzyme could 
generate higher amount of peptide fragments than complex structure of defatted skin. 
ACE inhibitory potency of peptides strongly depends on amino acid at C-terminal of 
peptides. Therefore, the proportion of some specific amino acids (Arg, Pro) is a 
critical factor providing high ACE inhibitory activity in alkaline-acid pretreated skin. 
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Table 4.3 Degree of hydrolysis, ACE inhibitory activity, peptide content and specific ACE inhibitory activity of hydrolysate 
produced by various enzyme and substrates. 
Enzyme Substrate 
ACE inhibition 
(%) 
DH 
(%) 
Peptide content 
(µg Gly eq.) 
Specific ACE inhibitory activity 
(%/µg Gly eq.) 
Alcalase Gelatin 32.3 35.1 68.5 0.5e
b
 
Defatted skin 44.1 38.4 77.3 0.6e
ab
 
Alkaline-acid pretreated skin 45.8 33.2 66.5 0.7e
a
 
Pepsin Gelatin 48.5 7.7 15.5 3.1b
a
 
Defatted skin 21.5 6.9 15.5 1.4cd
b
 
Alkaline-acid pretreated skin 71.0 7.7 14.5 4.9a
a
 
Trypsin Gelatin ND 12.3 35.8 ND 
Defatted skin ND 10.6 27.0 ND 
Alkaline-acid pretreated skin 62.6 11.7 34.3 1.9
c
 
Papain Gelatin ND 18.9 37.0 ND 
Defatted skin 25.4 13.9 30.9 0.8de
a
 
Alkaline-acid pretreated skin 63.4 17.0 36.0 1.8c
b
 
Protamex Gelatin 
Defatted skin 
Alkaline-acid pretreated skin 
21.5 
45.9 
59.4 
17.6 
12.3 
15.8 
35.9 
26.8 
34.5 
0.6c
b
 
1.7c
a
 
1.7e
a
 
7
1
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Table 4.3 Degree of hydrolysis, ACE inhibitory activity, peptide content and specific ACE inhibitory activity of hydrolysate 
produced by various enzyme and substrates (Continued). 
 
Data are express as mean ± SD (n = 4). SK 1-3-7 is V. halodenitrificans SK 1-3-7 protease. Letter is denoted as a significant 
difference among sample at P<0.05.  
Superscripts indicate significant difference on the individual protease at P<0.05.  
 
 
 
 
 
 
Enzyme Substrate 
ACE inhibition 
(%) 
DH 
(%) 
Peptide content 
(µg Gly eq.) 
Specific ACE inhibitory activity 
(%/µg Gly eq.) 
SK 1-3-7  Gelatin ND 18.9 46.3 ND 
Defatted skin ND 20.3 47.0 ND 
Alkaline-acid pretreated skin 29.1 22.4 48.5 0.6
e
 
7
2
 
 
 
 
 
 
 
 
 
 
73 
 
Table 4.4 Effect of substrates and enzymes on DH and specific ACE inhibitory activity. 
Factor 
Significance 
level (P)** 
Effect on DH* Effect on specific ACE inhibitory activity* 
Substrate <0.0001 
Gelatin ≥ Alkaline-acid pretrated skin ≥ 
Defatted skin 
 
Alkaline-acid pretreated skin >  
Defatted skin ≥ Gelatin  
 
Enzyme <0.0001 Alcalase > SK 1-3-7 > papain ≥  
Protamex > trypsin > pepsin 
  
Pepsin > Protamex > Papain ≥  
trypsin ≥ Alcalase ≥ SK 1-3-7  
 
Enzyme * Substrate <0.0001   
 
** Analysis based on sum of square. * Data were compared by DMRT. > indicates significantly higher than (P<0.05).  
≥ is higher than but not significant (P>0.05). SK 1-3-7 is V. halodenitrificans SK 1-3-7 protease. 
7
3
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4.3 Purification of ACE inhibitory peptides 
Both DH and ACE inhibitory activity increased with hydrolysis time (Figure 
4.2), indicating that ACE inhibitory activity of pepsin-hydrolyzed alkaline-acid 
pretreated Thai Panga skin hydrolysate relied on DH. During the progression of 
proteolysis, numbers of smaller peptides were released from the skin structure. Some 
of them might possess the chain length or C-terminal amino acid residues which could 
exert inhibitory activity towards ACE (Nasria et al., 2013; Salampessy, Reddy, 
Kailasapathy, and Phillips, 2015). ACE inhibitory activity rapidly increased within     
2 h and became steady afterward. Therefore, two hour hydrolysis is suitable for the 
production of potent ACE inhibitory hydrolysate.   
 
 
 
Figure 4.2 ACE inhibition (%) and degree of hydrolysis (%) of alkaline-acid 
pretreated skin produced by pepsin at different hydrolysis time. Values 
are expressed as mean ± SD (n=4). 
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 Results of ultrafiltration showed that peptides with MW < 1 kDa exhibited the 
highest ACE inhibitory activity and yield (P<0.05, Table 4.5). This result corresponds 
to the fact that small peptides contribute to the ACE inhibitory activity of protein 
hydrolysates. ACE has a small groove which restricts the access of large polypeptide 
to its active site (Hernández-Ledesma, Contreras, and Recio, 2011; Natesh, Schwager, 
Sturrock, and Acharya, 2003). The hydrolysate have MW less than that of the most 
potent ACE inhibitory peptide from tuna frame hydrolysate produced by pepsin which 
has MW 2,482 Da and IC50 = 11.3 µM (Lee, Qian, and Kim, 2010). The sequential 
ultrafiltration could effectively increase purity approximately 5 folds as compared to 
crude hydrolysates. Thus, the active fraction was further purified. 
 
Table 4.5 Ultrafiltration of pepsin-hydrolysed alkaline-acid pretreated skin.  
Fraction 
Peptide content 
(mg.Gly eq.) 
Yield (%) 
ACE inhibition 
(%) 
Crude  290.5 ± 1.4 100.0 9.3
c
 
> 30 kDa 34.6 ± 0.4 11.9 0.0
d
 
5-30 kDa 6.5 ± 0.1 2.2 45.5
b
 
1-5 kDa 3.0 ± 0.2 1.0 46.5
b
 
< 1 kDa 146.8 ± 2.3 50.5 49.8
a
 
 
Values are expressed as mean ± SD (n = 4). Yields were calculated based on peptide 
content (mg Gly eq.). Different letters indicate significant difference of ACE 
inhibition at the level of P<0.05. ACE inhibitions of fractions were determined at the 
same concentration of peptide (25 µg.Gly eq./mL). 
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Figure 4.3 (a) DEAE-Sephacel anion exchange chromatogram of pepsin-hydrolysed 
alkaline-acid pretreated skins hydrolysate (MW <1-kDa). Elution was 
performed at a flow rate of 1 mL/min with linear gradient of NaCl (0-1 
M) in 50 mM Tris-HCl buffer at pH 8.0. Bar graph indicates ACE 
inhibition (%). (b) Gel filtration chromatogram of active fraction A by 
DEAE-Sephacel column. Elution was performed at 0.2 mL/min with DI 
water. The fractions designated as I-VI were assayed for ACE inhibition 
(%). 
(a) 
[Type a quote from the 
document or the summary of an 
interesting point. You can 
position the text box anywhere in 
the document. Use the Drawing 
Tools tab to change the 
formatting of the pull quote text 
box.] 
(b) 
(a)  
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 The fraction sample (MW < 1 kDa) was subjected to DEAE-Sephacel anion 
exchange chromatography. Two fractions were obtained (Figure 4.3). The first elution 
(fraction A) was the active fraction with 51.2% ACE inhibition, while fraction B did 
not show ACE inhibitory activity at the same peptide concentration (25 µg. Gly 
eq./mL). The potent fraction A, was further separated by size-exclusion 
chromatography on Superdex Peptide 10/300 GL column. Five major peptide peaks 
were obtained. Only fraction V and its shoulder (fraction VI) exhibited ACE 
inhibitory activity. IC50 value of fraction V was determined to be 19 µg. Gly eq./mL. 
 Peptide sequences of fraction V from Superdex peptide 10/300 were analyzed 
by LC-MS/MS (Table 4.5). The potent fraction contained nine peptides consisting of 
7-13 amino acids with molecular mass between 0.7 and 1.5 kDa. The identified 
peptides contained a high proportion of hydrophobic amino acids (Phe, Pro, Leu, Val, 
Met, Tyr, and Trp). Amongst them, five peptides contained either hydrophobic (Leu 
or Val) or aromatic amino acids (Trp or Tyr) at the C-terminal while other four 
sequences possess Arg. Hydrophobic amino acids (Pro, Ala, Leu, Phe, and Val) were 
also located at the N-terminus of those peptides except for KEKLNPQPFVPR.   
 The molecular size (between 500-1500 Da and 3-13 amino acids length) and 
specific amino acids at the C-terminal of the identified peptides seem to be crucial 
factors regulating ACE inhibitory activity (Byun and Kim, 2002; Cheung, Wang, 
Ondetti, Sabo, and Cushman, 1980; Li, Leemail, Shi, and Shrestha, 2004; Jiangping 
Wu, Aluko, and Nakai, 2006). The sequences LNRVVERL, FLMKMRALFY, 
VFLVQRWWWV, VFLVQRWVWW and VFLRVQWREW showed some 
characteristics of a potent ACE inhibitory peptide according to Cheung, Wang, 
Ondetti, Sabo, and Cushman, (1980) who reported that Pro, hydrophobic, and 
aromatic amino acids at the C-terminal and branched-chain aliphatic amino acids (Val, 
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Ile, Leu) at the N-terminal can bind to ACE as a competitive inhibitor. Those 
preferred amino acids at the C-terminal tripeptide could tightly bind with the subsites 
(S’, S1’ and S2’) of the ACE catalytic site (Ondetti and Cushman, 1982).  
 
Table 4.6 ACE inhibitory peptide sequences identified by de novo peptide sequencing. 
Sequence no. 
Charge
a
 
(H
+
) 
m/z
b
 
MW 
(Da) 
Score Sequence 
1 2 499.80 997.60 82.22 LNRVVERL  
2 2 363.20 724.42 58.97 PSLPVGR 
3 2 363.20 724.45 53.84 ALLPVGR 
4 3 440.56 1318.69 45.61 FLMKMRALFY 
5 3 473.59 1417.76 45.61 VFLVQRWVWW 
6 3 473.59 1417.76 36.84 VFLVQRWWWV 
7 3 473.59 1417.76 33.33 VFLRVQWREW 
8 4 363.96 1451.82 31.88 KEKLNPQPFVPR 
9 4 363.96 1451.79 25.33 FPQPPLGTPFVPR 
 
a
 Charge state of the observed peptides. 
b
 Relation of mass/charge (m/z) observed in the LC-MS/MS system 
 
 The ACE inhibitory potency of Arg residue at the C-terminal was described by 
Meisel (1993). The positive charge on the guanidine or ε-amino group of the C-
terminal arginine and lysine side chain interacted with an anionic binding site of ACE 
other than the catalytic site (FitzGerald and Meisel, 2000). Peptides with Arg at C-
terminal have also been reported as the most potent ACE inhibitory peptide including: 
ALPMHIR (IC50 = 42.6 µM) derived from β-lactoglobulin of whey protein 
concentrate (Ferreiraa et al., 2007), IPALLKR (IC50 = 43 ± 1.3 µM) and 
AQQLAAQLPAMCR (IC50 = 68 ± 2.8 µM) from gluten (Asoodeh et al., 2014),  
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FQSNFNTQATNR (IC50 = 30 µM) from lysozyme (Asoodeh, Yazdi, and Chamani, 
2012),  and QLGPLGPR (IC50 = 148 µM) from skate skin collagen (Lee, Jeon, and 
Byun, 2011). Those peptides behaved as a non-competitive, competitive, 
uncompetitive inhibitor and non-competitive inhibitor, respectively (Asoodeh et al., 
2014; Asoodeh, Yazdi, and Chamani, 2012; Lee, Jeon, and Byun, 2011).  
 Peptide sequences found in this study have not yet been reported in the  
literatures. Nevertheless, amino acid residues at the ultimate and penultimate position 
of Thai Panga skin peptides, FPQPPLGTPFVPR and KEKLNPQPFVPR, had a 
homology with the first two residues from C-terminal of ACE inhibitory peptide from 
soya milk (WNPR, IC50 = 880 µM) (Tomatsu, Shimakage, Shinbo, Yamada, and 
Takahashi, 2013), skate skin (QLGFLGPR, IC50 = 148 µM) (Lee, Jeon, and Byun, 
2011), and skipjack roe (YVNDAATLLPR, IC50 = 105.9 µM) (Intarasirisawat, 
Benjakul, Wu, and Visessanguan, 2013). In addition, the first two residues from       
C-terminal of VFLVQRWVWW of Thai Panga alkaline-acid pretreated skin was 
similar to the potent ACE inhibitory peptide from bullfrog muscle 
(GAAGLPCSADWW, IC50 = 1.0 µM) (Qian, Jung, Lee, Byun, and Kim, 2007). 
 
4.4 Effect of gastrointestinal proteases on ACE inhibitory activity 
The effective ACE inhibitory peptides need to preserve their active form until 
reach the target site in vivo. Gastrointestinal digestion might increase or decrease ACE 
inhibitory activity of the peptide (Jao, Huang, and Hsu, 2012). A simulated peptic-
pancreatic digestion can be used to predict the fate of ACE inhibitory potency after 
orally ingested (Hur, Lim, Decker, and McClements, 2011). After pepsin hydrolysis, 
ACE inhibitory activity remained the same, but decreased after pancreatic digestion. 
The α-amino acid group content increased after peptic-pancreatic incubation (Figure 
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4.5), indicating that those peptides were mostly degraded by pancreatin. Long chain 
peptides (more than 5 amino acid residues) appeared to be prone to pancreatin 
digestion via several proteases (trypsin, chymotrypsin, elastase, carboxypeptidases A 
and B) (Barrett, Rawlings, and Woessner, 2004; Coffee, 1998). The potent amino 
acids at C-terminal (Arg, Trp, Phe, Tyr, and Leu) of some ACE inhibitory peptides 
could be liberated by carboxypeptidase A and B, resulting in  inactive forms. The 
peptides may be classified as a substrate of ACE (Fujita, Yokoyama, and Yoshikawa, 
2000), which they lost their ACE inhibitory activity after gastrointestinal digestion. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5 (A) α-Amino acid content (mg. Gly eq./mL) and (B) ACE inhibitory 
activity of the partially-purified peptides at the same peptide concentration 
(20 µg. Gly eq./mL) after incubation by pepsin for 3 h followed by 
pancreatin for 4 h. 
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CHAPTER V 
SUMMARY 
 
 Thai Panga skin is a rich source of protein. Pretreatment of Thai Panga skin 
with butyl alcohol or alkaline-acid extraction increased protein content. Defatted and 
alkaline-acid pretreatred skin composed of type I collagen. Thermal extraction process 
of gelatin at 50
oC induced degradation of α1-chain into smaller peptide fragments. 
Defatted and alkaline-acid pretreated skin contained Asp, Glu/Gln and Ser higher than 
gelatin, while alkaline-acid pretreated skin and gelatin contained Pro higher than 
defatted skin. Enzymatic protein hydrolysates from Thai Panga skin showed potential 
to inhibit ACE when prepared using alkaline-acid pretreated skin and pepsin at 2 h of 
hydrolysis time. The consecutive fractionation of ultrafiltration, anion exchanger and 
size-exclusion chromatography could improve the purity approximately 5 folds as 
compared to crude hydrolysates. The partially-purified peptides showed IC50 of 19 µg 
Gly eq./mL with molecular mass between 0.7-1.5 kDa and composed of hydrophobic, 
aromatic amino acids or Arg at their C-terminal position. ACE inhibitory peptides 
from Thai Panga skin were classified as a substrate type ACE inhibitor as their ACE 
inhibitory activity decreased after a simulated in vitro peptic-pancreatic incubation. 
Production of ACE inhibitory peptides could be an efficient utilization of by-product 
from Thai Panga industry. To develop a functional food, the in vivo efficacy is 
essential to validate their role in lowering blood pressure. 
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